書籍詳細

第1章 基礎生物医学の発展

P.8 掲載の参考文献

• 1) 立野知世, 吉里勝利:肝臓と皮膚の細胞増殖・分化と再生. 生化学 2005, 8:655-659.

• 2) Lemaigre F, Zaret, KS:Liver development update:new embryo models, cell lineage control and morphogenesis. Curr Opin Genet Dev 2004, 14:582-590

• 3) Steiner JW, Perz M, Taichman LB:Cell population dynamics in the liver. A review of quantitative morphoiogical techniques applied to the study of physiological and pathological growth. Exp Mol Pathol 1966, 5:146-181

• 4) Fausto N:Liver regeneration and repair:hepatocytes, progenitor cells, and stem cells. Hepatology 2004, 39:1477-1487

• 5) Walkup MH, Gerber DA:Hepatic stem cells:in search of. Stem Cells 2006, 24:1833-1840.
  pubmed

• 6) Yovchev MI, Grozdanov PN, Joseph B, Gupta S, Debeva MD:Novel hepatic progenitor cell surface markers in the adult rat liver. Ilepatology 2007, 45:139-149

• 7) Asahina K, Shiokawa M, Ueki T, Yamasaki C, Aratani A et al.:Multiplicative mononuclear small hepatocytes in adult rat liver:their isolation as a homogeneous population and localization to periportal zone. Bioche Biophys Res Commun 2006, 342:1160-1167

• 8) Kon J, Ooe h, Oshima H, Kikkawa Y, Mitaka T:Expression of CD44 in rat hepatic progenitor cells. J hepatol 2006, 45:90-98

• 9) Yamasaki C, Tateno C, Aratani A, Onishi C. Katayama S et al.:Growth and differentiation of colony-forming human hepatocytes in vitro. J Hepatol 2006. 44:749-757

• 10) Elaine F:Scratching the surface of skin development. Nature 2007, 445:834-842.

• 11) Amoh Y, Li L, Katsuoka K, Penman S, Hoffman RM:Multopotent nestin-positive, keratin-negative hair-follocle bulge stem cells can form neurons. Proc Natl Acad Sci USA 2005, 100:9958-9961.

• 12) Yu H, Fang D, Kumar SM, Li L, Nguyen TK et al.:Isolation of a novel population of multipotent adult stem cells from human hair follocles. Am J Pathol 2006, 168:1879-1887.

• 13) Schmalbrunch H, Lewis DM:Dynamics of nuclei of muscle fibers and connective tissue cells in normal and denervated rat muscles. Muscle Nerve 2000, 23:617-626.
  pubmed

• 14) Morgan JE, Partridge TA:Muscle satellite cells. Int J Biochem Cell Biol 2003, 35:1151-1156.
  pubmed

• 15) Seale P, Sabourin LA, Girgis-Gabardo A, Mansouri A, Gruss P, Rundnicki MA:Pax7 is required for the specification of myogenic satellite cells. Cell 2000, 102:777-786.

• 16) Zammit PS, Partridge TA, Yablonka-Reuveni Z:The skeletal muscle satellite cell:the stem cell that came in from the cold. J Histochem Cytochem 2006, 54:1177-1191.

• 17) Asakura A, Komaki M, Rudnicki MA:Muscle satellite cells are multipotential stem cell that exhibit myogenic, ostegenic, and adipogenic differentiation. Differentiation 2001, 68:245-253.

• 18) Shefer G, Wleklinski-Lee M, Yablonka-Reuveni Z:Skeletal muscle satellite cells can spontaneously enter an alternative mescenchymal pathway. J Cell Sci 2004, 117:5393-5404.

• 19) Wada MR, Inagawa-Ogashiwa M, Shimizu S, Yasumoto S, Hashimoto N:Generation of different fates from multipotent muscle stem cells:Development 2002, 129:2987-2995.
  pubmed

P.16 掲載の参考文献

• 1) Gage FH:Mammalian neural stem cells. Science , 287:1433-1438.
  pubmed

• 2) Doetsch F, Caille I, Lim DA, Garcia-Verdugo JM, Alvarez-Buylla A:Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 1999, 97:703-716.
  pubmed

• 3) Palmer TD, Takahashi J, Gage FH:The adult rat hippocampus contains primordial neural stem cells. Molecular and cellular neurosciences 1997, 8:389-404.
  pubmed

• 4) Li L, Xie T:Stem cell niche:structure and function. Annual review of cell and developmental biology 2005, 21:605-631.

• 5) Shen Q et al.:Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 2004, 304:1338-1340.
  pubmed

• 6) Davis AA, Temple SA:self-renewing multipotential stem cell in embryonic rat cerebral cortex. Nature 1994, 372:263-266.

• 7) Reynolds BA, Tetzlaff W, Weiss S:Amuitipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes. J Neurosci 1992, 12:4565-4574.
  pubmed

• 8) Lendahl U, Zimmerman LB, McKay RD:CNS stemcells express a new class of intermediate filamentprotein. Cell 1990, 60:585-595.

• 9) Sakakibara S et al.:Mouse-Musashi-1, a neural RNA-binding protein highly enriched in the mammalian CNS stem celL Developmental biology 1996, 176:230-242.
  pubmed

• 10) Kawaguchi A et al.:Nestin-EGFP transgenic mice:visualization of the self-renewal and muitipotency of CNS stem cells. Molecular and cellular neurosciences 2001, 17:259-273.
  pubmed

• 11) Pincus DW et al.:Fibroblast growth factor-2/brain-derived neurotrophic factor-associated maturation of new neurons generated from adult human subependymal cells. Annals of neurology 1998, 43:576-585.
  pubmed

• 12) Roy NS et al.:In vitro neurogenesis by progenitor cells isolated from the adult human hippocampus. Nature medicine 2000, 6:271-277.
  pubmed

• 13) Roy NS et al.:Promoter-targeted selection and isolation of neural progenitor cells from the adult human ventricular zone. Journal of neuroscience research 2000, 59:321-331.
  pubmed

• 14) Rietze RL et al.:Purification of a pluripotent neural stem cell from the adult mouse brain. Nature 2001, 412:736-739.
  pubmed

• 15) Murayama A, Matsuzaki Y, Kawaguchi A, Shimazaki T, Okano H:Flow cytometric ana!ysis of neural stem cells in the developing and adult mouse brain. Journal of neuroscience research 2002, 69:837-847.

• 16) Bain G, Kitchens D, Yao M, Huettner JE, Gottlieb DI:Embryonic stem cells express neuronal properties in vitro. Developmental biology 1995, 168, 342-357.
  pubmed

• 17) Wichterle H, Lieberam I, Porter JA, Jessell TM:Directed differentiation of embryonic stem cells into motor neurons. Cell 2002, 110:385-397.
  pubmed

• 18) Lee SH, Lumelsky N, Studer L, Auerbach JM, McKay RD:Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nature biotechnology 2000, 18, 675-679.
  pubmed

• 19) Kawasaki H et al.:Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 2000, 28:31-40.
  pubmed

• 20) Kawasaki H et al.:Generation of dopaminergic neurons and pigmented epithelia from primate ES cells by stromal cell-derived inducing activity. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:1580-1585.
  pubmed

• 21) Tropepe V et al.:Direct neural fate specification from embryonic stem cells:aprimitive mammalian neural stem cell stage acquired through a default mechanism. Neuron 2001, 30:65-78.

• 22) Kato T et al.:Aneurosphere-derived factor, cystatin C, supports differentiation of ES cells into neural stem cells. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:6019-6024.
  pubmed

• 23) Barberi T et al.:Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application ill parkinsonian mice. Nature biotechnology 2003, 21:1200-1207.

• 24) Thomson JA et al.:Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
  pubmed

• 25) Reubinoff BE, Pera MF, Fong CY, Trounson A, Bongso A:Embryonic stem cell lines from human blastocysts:somatic differentiation in vitro. Nature biotechnology 2000, 18:399-404.
  pubmed

• 26) Reubinoff BE et al.:Neural progenitors from human embryonic stem cells. Nature biotechnology 2001, 19:1134-1140.

• 27) Carpenter MK et al.:Enrichment of neurons and neural precursors from human embryonic stem cells. Experimental neurology 2001, 172:383-397.
  pubmed

• 28) Etchevers HC, Vincent C, Le Douarin NM, Couly GF:The cephalic neural crest provides pericytes and smooth muscle cells to all blood vessels of the face and forebrain. Development 2001, 128:1059-1068.
  pubmed

• 29) Kirby ML, Gale TF. Stewart DE:Neural crest cells contribute to normal aorticopulmonary septation. Science 1983, 220:1059-1061.
  pubmed

• 30) Kirby ML, Stewart DE:Neural crest origin of cardiac ganglion cells in the chick embryo:identification and extirpation. Developmental biology 1983, 97:433-443.
  pubmed

• 31) Yntema CL, Hammond WS:The origin of intrinsic ganglia of trunk viscera from vagal neural crest in the chick embryo. The Journal of comparative neurology 1954, 101:515-541.
  pubmed

• 32) Burns AJ, Douarin NM:The sacral neural crest contributes neurons and glia to the post-umbilicalgut:spatiotemporal analysis of the development of the ellteric nervous system. Development 1998, 125:4335-4347.

• 33) Morrison SJ, White PM, Zock C, Anderson DJ:Prospective identification, isolation by flow cytometry, and in vivo self-renewal of multipotent mammalian neural crest stem cells. Cell 1999, 96:737-749.
  pubmed

• 34) Stemple DL, Anderson DJ:Isolation of a stem cell for neurons and glia from the mammalian neural crest. Cell 1992, 71:973-985.
  pubmed

• 35) Danielian PS, Muccino D, Rowitch DH, Michael SK, McMahon AP:Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Curr Biol 1998, 8:1323-1326.
  pubmed

• 36) Yamauchi Y et al.:Anovel transgenic technique that allows specific marking of the neural crest cell lineage in mice. Developmental biology 1999, 212:191-203.

• 37) Li J, Chen F, Epstein JA:Neural crest expression of Cre recombinase directed by the proximal Pax3 promoter in transgenic mice. Genesis 2000, 26:162-164.

• 38) Pietri T, Eder O, Blanche M, Thiery JP, Dufour S:The human tissue plasminogen activator-Cre mouse:anew tool for targeting specifically neural crest cells and their derivatives in vivo. Developmental biology 2003, 259:176-187.

• 39) Bixby S, Kruger GM, Mosher JT, Joseph NM, Morrison SJ:Cell-intrinsic differences between stem cells from different regions of the peripheral nervous system regulate the generation of neural diversity. Neuron 2002, 35:643-656.
  pubmed

• 40) Kruger GM et al.:Neural crest stem cells persist in the adult gut but undergo changes in self-renewal, neuronal subtype potential, and factor responsiveness. Neuron 2002, 35:657-669.
  pubmed

• 41) Toma JG et al.:Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nature cell biology 2001, 3:778-784.
  pubmed

• 42) Fernandes KJ et al.:Adermal niche for multipotent adult skin-derived precursor cells. Nature cell biology 2004, 6:1082-1093.
  pubmed

• 43) Wong CE et al.:Neural crest-derived cells with stem cell features can be traced back to multiple lineages in the adult skin. The Journal of cell biology 2006, 175:1005-1015.
  pubmed

• 44) Toma JG, McKenzie IA, Bagli D, Miller FD:Isolation and characterization of multipotent skinderived precursors from human skin. Stem Cells 2005, 23:727-737.
  pubmed

• 45) Tomita Y et al.:Cardiac neural crest cells contribute to the dormant multipotent stem cell in the mammalian heart. The Journal of cell biology 2005, 170:1135-1146.

• 46) Yoshida S et al.:Isolation of multipotent neural crest-derived stem cells from the adult mouse cornea. Stem cells 2006, 24:2714-2722.
  pubmed

• 47) Tonchev AB, Yamashima T, Zhao L, Okano HJ, Okano H:Proliferation of neural and neuronal progenitors after global brain ischemia in young adult macaque monkeys. Molecular and cellular neurosciences 2003, 23:292-301.
  pubmed

• 48) Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O:Neuronal replacement from endogenous precursors in the adult brain after stroke. Nature medicine 2002, 8:963-970.
  pubmed

• 49) Yamashita T et al.:Subventricular zone-derived neuroblasts migrate and differentiate into mature neurons in the post-stroke adult striatum. J Neurosci 2006, 26:6627-6636.
  pubmed

• 50) Lindvall O, Bjorklund A:Transplantation strategies in the treatment of Parkinson's disease:experimental basis and clinical trials. Acta neurologica Scandinavica 1989, 126:197-210.
  pubmed

• 51) Sawamoto K et al.:Generation of dopaminergic neurons in the adult brain from mesencephalic precursor cells labeled with a nestin-GFP transgene. J Neurosci 2001, 21:3895-3903.
  pubmed

• 52) Ogawa Y et al.:Transplantation of in vitroexpanded fetal neural progenitor cells results in neurogenesis and functional recovery after spinal cord contusion injury in adult rats. Journal of neuroscience research 2002, 69:925-933.
  pubmed

• 53) Iwanami A et al.:Transplantation of human neural stem cells for spinal cord injury in primates. Journal of neuroscience research 2005, 80:182-190.
  pubmed

• 54) Iwanami A et al.:Establishment of graded spinal cord injury model in a nonhuman primate:the common marmoset. Journal of neuroscience research 2005, 80:172-181.

• 55) Hofstetter CP et al.:Allodynia limits the usefulness of intraspinal neural stem cell grafts;directed differentiation improves outcome. Nature neuroscience 2005, 8:346-353.
  pubmed

• 56) Brustle O et al.:Embryonic stem cell-derived glial precursors:a source of myelinating transplants. Science 1999, 285:754-756.
  pubmed

• 57) Kim JH et al.:Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 2002, 418:50-56.

• 58) Dinsmore J et al.:Embryonic stem cells differentiatcd in vitro as a novel source of cells for transplantation. Cell transplantation 1996, 5:131-143.
  pubmed

• 59) Ben-Hur T et al.:Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in Parkinsonian rats. Stem cells 2004, 22:1246-1255.
  pubmed

• 60) Kerr DA et al.:Human embryonic germ cell derivatives facilitate motor recovery of rats with diffuse motor neuron injury. J Neurosci 2003. 23:5131-5140.
  pubmed

• 61) Keirstead HS et al.:Human embryonic stem cellderived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci 2005, 25:4694-4705.
  pubmed

• 62) Takahashi K, Yamanaka S:Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006. 126:663-676.
  pubmed

• 63) McKenzie IA, Biernaskie J, Toma JG, Midha R, Miller FD:Skin-derived precursors generate myelinating Schwann cells for the injured and dysmyelinated nervous system. J Neurosci 2006, 26:6651-6660.
  pubmed

• 64) Fernandes KJ et al.:Analysis of the neurogenic potential of multipotent skin-derived precursors. Experimental neurology 2006, 201:32-48.
  pubmed

• 65) Sieber-Blum M et al.:Characterization of epidermal neural crest stem cell(EPI-NCSC) grafts in the lesioned spinal cord. Molecular and cellular neurosciences 2006, 32:67-81.
  pubmed

P.23 掲載の参考文献

• 1) Takahashi K, Yamanaka S:Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:633-676.

• 2) Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ et al.:Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
  pubmed

• 3) Bjorklund LM, Sanchez-Pernaute R, Chung S, Andersson T, Chen IY et al.:Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci USA 2002, 99:2344-2349.

• 4) Kim D, Gu Y, Ishii M, Fujimiya M, Qi M et al.:In vivo functioning and transplantable mature pancreatic islet-like cell clusters differentiated from embryonic stem cell. Pancreas 2003, 27:e34-e41.

• 5) Tada M, Takahama Y, Abe K, Nakatsuji N, Tada T:Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr Biol 2001, 11:1553-1558.
  pubmed

• 6) Wakayama T, Perry AC, Zuccotti M, Johnson KR, Yanagimachi R:Full-term development of mice from enucleated oocytes injected with cumulus cell nuclei. Nature 1998, 394:369-374.
  pubmed

• 7) Cowan CA, Atienza J, Melton DA, Eggan K:Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 2005, 309:1369-1373.
  pubmed

• 8) Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M et al.:The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 2003, 113:631-642.
  pubmed

• 9) Takahashi K, Mitsui K, Yamanaka S:Role of ERas in promoting tumour-like properties in mouse embryonic stem cclls. Nature 2003, 23:541-545.

• 10) Maruyama M, Ichisaka T, Nakagawa M, Yamanaka S:Differential roles for Sox15 and Sox2 in transcriptional control in mouse embryonic stem cells. J Biol Chem 2005, 280:24371-24379.
  pubmed

• 11) Tokuzawa Y, Kaiho E, Maruyama M, Takahashi K, Mitsui K et al.:Fbx15 is a novel target of Oct3/4 but is dispensable for embryonic stem cell self-renewal and mouse development. Mol Cell Biol 2003, 23:2699-2708.
  pubmed

• 12) Hochedlinger K, Yamada Y, Beard C, Jaenisch R:Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 2005, 121:465-477.
  pubmed

P.28 掲載の参考文献

• 1) 京都大学再生医科学研究所:ヒトES細胞情報公開ウェブサイト. http://www.shigen.nig.ac.jp/escell/human/top.jsp

• 2) James D, Levine AJ, Besser D, Hemmati-Brivanlou A:TGF β/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 2005, 132(6):1273-1282.

• 3) Sato N Meijer L, Skaltsounis L, Greengard P, Brivanlou AII:Maintenance of pluripotency in human and mouse embryonic stem cells throughactivation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med 2004, 10(1):55-63.

• 4) Xu RH, Peck RM, Li DS, Feng X, Thomson JA et al.:Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat Methods 2005, 2(3):185-190.
  pubmed

• 5) Sumi T, Tsuneyoshi N Nakatsuji N, Suemori H:Apoptosis and differentiation of human embryonic stem cells induced by sustained activation of c-Myc. Oncogene 2007, (in press) .

• 6) Fujioka T, Yasuchika K Nakamura Y, Nakatsuji N, Suemori H:Asimple and efficient cryopreservation method for primate embryonic stem cells. Int J Dev Biol 2004, 48(10):1149-1154.

• 7) Skottman H, Hovatta O:Culture conditions for human embryonic stem cells. Reproduction 2006, 132(5):691-698.
  pubmed

• 8) Ludwig TE, Levenstein ME, Jones JM, Berggren WT, Thomson JA et al.:Derivation of human embryonic stem cells in defined conditions. Nat Biotechnol 2006, 24(2):185-187.
  pubmed

• 9) Cowan CA, Atienza J, Douglas A. Melton DA, Eggan K:Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 2005, 309(5739):1369-1373.

• 10) Matsumura H, Tada M, Otsuji T, Yasuchika K, Tada Tet al.:Targeted chromosome elimination from ES-somatic hybrid cells. Nat Methods 2007, 4(1):23-25.

• 11) Takahashi K, Yamanaka S:Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126 (4):663-676.
  pubmed

• 12) Nakajima F, Tokunaga K, Nakatsuji N:HLA matching estimations in a hypothetical bank of human embryonic stem cell lines in the Japanese population for use in cell transplantation therapy. Stem Cells 2007, 25(4):983-985.

• 13) 文部科学省ウェブサイト http://www.mext.go.jp/a_menu/shinkou/seimei/main.htm

• 14) Daley GQ, Ahrlund Richter L, Auerbach JM, Benvenisty N, Zoloth L et al.:Ethics. The ISSCR guidelines for human embryonic stem cell research. Science 2007, 315(5812):603-604.
  pubmed

P.34 掲載の参考文献

• 1) Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC:Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 1996, 183:1797-1806.
  pubmed

• 2) Goodell MA, Rosenzweig M, Kim H, Marks DF, DeMaria M et al.:Dye efflux studies suggest that hematopoietic stem cells expressing lower undetectable levels of CD34 antigen exist in multiple species. Nat Med 1997, 3:1337-1345.

• 3) Zhou S. Schuetz JD, Bunting KD, Colapietro AM, Sampath J et al.:The ABC transporter BCRP1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 2001, 7:1028-1034.

• 4) Pearce DJ, Ridler CM, Simpson C, Bonnet D:Multiparameter analysis of murine bone marrow side population cells. Blood 2004, 103:2541-2546.
  pubmed

• 5) Matsuzaki Y, Kinjo K, Mulligan RC, Okano H:Unexpectedly efficient homing capacity of purificd murine hematopoietic stem cells. Immunity 2004, 20:87-93.
  pubmed

• 6) Camargo FD. Chambers SM, Drew E, McNagny KM, Goodell MA:Hematopoietic stem cells do Ilot engraft with absolute efficiencies. Blood 2006, 107:501-507.

• 7) Gussoni E, Soneoka Y, Strickland CD, Buzney EA, Khan MK et al.:Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 1999, 401:390-394.
  pubmed

• 8) Larderet G, Fortunel NO, Vaigot P, Cegalerba M Maltere P et al.:Human side population keratinocytes exhibit long-term proliferative potential and a specific gene expression profile and can form a pluristratified epidermis. Stem Cells 2006, 24:965-974.

• 9) Redvers RP, Li A, Kaur P:Side population in adult murine epidermis exhibits phenotypic and functional characteristics of keratinocyte stem cells. Proc Natl Acad Sci USA 2006, 103:13168-13173.
  pubmed

• 10) Wulf GG, Luo KL, Jackson KA, Brenner MK, Goodell MA:Cells of the hepatic side population contribute to liver regeneration and can be replenished with bone marrow stem cells. Haematologica 2003, 88:368-378.
  pubmed

• 11) Falciatori I, Borsellino G, Haliassos N Boitani C, Corallini S et al.:Identification and enrichment of spermatogonial stem cells displaying side-population phenotype in immature mouse testis. Faseb J 2004, 18:376-378.
  pubmed

• 12) Osawa M. Hanada K, Hamada H, Nakauchi H:Longterm lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 1996, 273:242-245.
  pubmed

• 13) Shackleton M, Vaillant F, Simpson KJ, Stingl J, Smyth GK et al.:Generation of a functional mammary gland from a single stem cell. Nature 2006, 439:84-88.
  pubmed

• 14) Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM, Fike JR, Lee HO et al.:Fusion of bone-marrow. derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 2003, 425:968-973.
  pubmed

• 15) Bonnet D, Dick JE:Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997, 3:730-737.
  pubmed

• 16) Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF:Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003, 100:3983-3988.
  pubmed

• 17) Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ:Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005, 65:10946-10951.
  pubmed

• 18) Wulf GG, Wang RY, Kuehnle I, Weidner D, Marini Fet al.:Aleukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia. Blood 2001, 98:1166-1173.

• 19) Haraguchi N, Utsunomiya T, Inoue H, Tanaka F, Mimori K et al.:Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells 2006, 24:506-513.
  pubmed

• 20) Kondo T, Setoguchi T, Taga T:Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA 2004, 101:781-786.
  pubmed

• 21) Grichnik JM, Burch JA, Schulteis RD, Shan S, Liu J et al.:Melanoma, a tumor based on a mutant stem cell? J Invest Dermatol 2006, 126:142-153.
  pubmed

• 22) Seigel GM, Campbell LM, Narayan M, Gonzalez-Fernandez F:Cancer stem cell characteristics in retinoblastoma. Mol Vis 2005, 11:729-737.
  pubmed

• 23) Zhou S, Morris JJ, Barnes Y, Lan L, Schuetz JD et al.:BCRPI gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo. Proc Natl Acad Sci USA 2002, 99:12339-12344.

• 24) Morita Y, Ema H, Yamazaki S, Nakauchi H:Nonside-population hematopoietic stem cells in mouse bone marrow. Blood 2006, 108:2850-2856.

• 25) Krishnamurthy P, Ross DD, Nakanishi T, Bailey-Dell K, Zhou S et al.:The stem cell markcr Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme. J Biol Chem 2004, 279:24218-24225.
  pubmed

• 26) Parmar K. Mauch P, Vergilio JA, Sackstein R, Down JD:Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc Natl Acad Sci USA 2007, 104:5431-5436.
  pubmed

• 27) Ifergan I, Shafran A, Jansen G, Hooijberg JH, Scheffer GL et al,:Folate deprivation results in the loss of breast cancer resistance protein (BCRP/ABCG2) expression. A role for BCRP in cellular folate homeostasis. J Biol Chem 2004, 279:25527-25534.
  pubmed

P.41 掲載の参考文献

• 1) Forest C, Czerucka D, Negrel R, Ailhaud G:Establishment of a human cell line after transformation by a plasmid containing the early region of the SV40 genome. Cell Biol Int Rep 1983, 7:73-81.
  pubmed

• 2) Lane DP:Cell immortalization and transformation by the p53 gene. Nature 1984, 312:596-597.
  pubmed

• 3) Jenkins JR, Rudge K, Currie GA:Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53. Nature 1984, 312:651-654.
  pubmed

• 4) Mayne LV, Priestley A, James MR, Burke JF:Efficient immortalization and morphological transformation of human fibroblasts by transfection with SV40 DNA linked to a dominant marker. Exp Cell Res 1986, 162:530-538.
  pubmed

• 5) Bondar AG:Extension of life-span by introduction of telomerase into normal human cells. Science 1998, 279:349-352.

• 6) Zhu J, Wang H, Bishop JM, Blackburn EH:Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening. Proc Natl Acad Sci USA 1999, 96:3723-3728.
  pubmed

• 7) Halvorsen TL, Leibowitz G, Levine F:Telomerase activity is sufficient to allow transformed cells to escape from crisis. Mol Cell Biol 1999, 19:1864-1870.

• 8) Noguchi H, Kobayashi N Westerman KA et al.:Controlled expansion of human endothelial cell populations by Cre/loxP-based reversible immortalization. Hum Gene Ther 2002, 13:321.
  pubmed

• 9) Shay JW, Wright WE:Quantitation of the frequency of immortalization of normal human diploid fibroblasts by SV40T large T-antigen. Exp Cell Res 1989, 184:109-118.

• 10) Maruyama M, Kobayashi N, Westerman KA et al.:Establishment of a highly differentiated immortalized human cholangiocyte cell line with SV40T and hTERT. Transplantation 2004, 77:446-451.
  pubmed

• 11) Matsumura T, Takesue M, Westerman KA et al.:Establishment of an immortalized human liver endothelial cell line with SV40T and hTERT. Transplantation 2004, 77:1357-1365.
  pubmed

• 12) Narushima M, Kobayashi N, Okitsu T, Tanaka Y, Li SA et al.:A human β-cell line for transplantation therapy to control type 1 diabetes. Nat Biotechnol 2005, 23:1274-1282.

• 13) Sternberg N, Hamilton D:Bacteriophage P1 sitespecific recombination I. Recombination between loxP sites. J Mol Biol 1981, 150:467-486.

• 14) Westerman KA, Leboulch P:Reversible immortalization of mammalian celis mediated by retroviral transfer and site-specific recombination. Proc Natl Acad Sci 1996. 93:8971-8976.

• 15) Kobayashi N, Fujiwara T, Westerman KA et al.:Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. Science 2000, 287:1258-1262.
  pubmed

• 16) Watanabe T, Shibata N, Westerman KA et al.:Establishment of immortalized human hepatic stellate scavenger cells to develop bioartificial livcrs. Transplantation 2003, 75:1873-1880.
  pubmed

• 17) Nagahara H, Vocero-Akbani AM, Snyder EL et al.:Transduction of full-length TAT fusion proteins into mammalian cells:TAT-p27Kipl induced cell migration. Nat Med 1998, 4:1449-1452.

• 18) Okitsu T, Kobayashi N, Jun HS et al.:Transplantation of reversibly immortalized insulinsecreting human hepatocytes controls diabetes in pancreatectomized pigs. Diabetes 2004, 53:105-112.
  pubmed

• 19) Totsugawa T, Yong C, Soto-Gutierrez A et al.:Survival of liver failure pigs by transplantation of reversibly immortalized human hepatocytes with tamoxifen-mediated self-recombination. J Hepatol, (in press) .

P.47 掲載の参考文献

• 1) Grapin-Botton A, Melton DA:Endoderm development:from patterning to organogenesis. Trends Genet 2000, 16(3):124-130.
  pubmed

• 2) 福田公子, 八杉貞雄:消化管の領域化と器官形成. 蛋白質 核酸 酵素 2005, 50(6):670-677.

• 3) Gualdi R. Bossard P, Zheng M, Hamada Y, Coleman JR, Zaret KS:Hepatic specification of the gut endoderm in vitro:cell signalling and transcriptional control. Genes Dev 1996, 10:1670-1682.

• 4) Shiojiri N:Development and differentiation of bile ducts in the mammalian liver. Microsc Res Tech 1997, 15:328-335.

• 5) Jung J, Zheng M, Goldfarb M, Zaret KS:Initiation of mammalian liver development from endoderm by fibroblasts growth factors. Science 1999, 284:1998-2003.
  pubmed

• 6) Rossi JM, Dunn NR, Hogan BL, Zaret KS:Distinct mesodermal signals, including BMPs from the septum transversum mesenchyme, are required in combination for hepatogenesis from the endoderm. Genes & Dev 2001. 15:1998-2009.
  pubmed

• 7) Rojas A, De Val S, IIeidt AB, Xu SM, Bristow J, Black BL:Gata4 expression in lateral mesoderm is downstream of BMP4 and is activated directly by Forkhead and GATA transcription factors through adistal enhancer element. Development 2005, 132 (15):3405-3417.

• 8) Calmont A, Wandzioch E, Tremblay KD, Minowada G, Kaestner KH et al.:An FGF response pathway that mediates hepatic gene induction in embryonic endoderm cells. Dev Cell 2006, 11(3):339-348.
  pubmed

• 9) Ober EA, Verkade H, Field HA, Stainier DY:Mesodermal Wnt2b signalling positively regulates liver specification. Nature 2006, 442:688-691.
  pubmed

• 10) Matsumoto K, Yoshitomi H, Rossant J, Zaret KS:Liver organogenesis promoted by endothelial cells prior to vascular function. Science 2001, 294:559-563.
  pubmed

• 11) Bladt F, Riethmacher D, Isenmann S, Aguzzi A, Birchmeier C:Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature 1995, 376:768-771.

• 12) Schmidt C, Bladt F, Goedecke S, Brinkmann V, Zschiesche W et al.:Scatter factor/hepatocyte growth factor is essential for liver development. Nature 1995, 373:699-702.
  pubmed

• 13) Uehara Y, Minowa O, Mori C, Shiota K, Kuno J et al.:Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 1995, 373:702-705.
  pubmed

• 14) Shiojiri N:Development and differentiation of bile ducts in the mammalian liver. Microsc Res Tech 1997, 39:328-335.
  pubmed

• 15) Lemaigre FP:Development of the biliary tract. Mech Dev 2003, 120(1):81-87.
  pubmed

• 16) Tanimizu N, Miyajima A:Notch signaling controls hepatoblast differentiation by altering the expression of liver-enriched transcription factors. J Cell Sci 2004, 117:3165-3174.
  pubmed

• 17) Koike T, Yasugi S:In Vitro analysis of mesenchymal influuences on the differentiation of stomach epithelial cells of the chicken embryo. Differentiation, 1999, 65:13-25.
  pubmed

• 18) Narita T, Saitoh K, Kameda T, Kuroiwa A, Mizutani M et al.:BMPs are necessary for stomach gland formation in the chicken embryo:a study using virally induced BMP-2 and Noggin expression. Development 2000, 127(5):981-988.
  pubmed

• 19) Sukegawa A, Narita T, Kameda T, Saitoh K, Nohno Tet al.:The concentric structure of the developing gut is regulated by sonic hedgehog derived from endodermal epithelium. Development 2000, 127:1971-1980.

• 20) Sukegawa A, Narita T, Kameda T, Saitoh K et al.:The concentric structure of the developing gut is regulated by Sonic hedgehog derived from endodermal epithelium. Development 2000, 127 (9):1971-1980.
  pubmed

• 21) Expression of the novel extracellular matrix component tenascin in normal and diseased human liver. An immunohistochemical study. J Hepatol 1990, 11:43-52.
  pubmed

• 22) Omenetti A, Yang L, Li YX, McCall SJ, Jung Y et al.:Hedgehog-mediated mesenchymal-epithelial interactions modulate hepatic response to bile duct ligation. Lab Invest 2007, (in press) .

• 23) Michalopoulos GK, DeFrances MC:Liver regeneration. Science 1997, 276:60-66.
  pubmed

• 24) Gerber MA, Thung SN:Liver stem cells and develipment(editorial) . Lab Invest 1993, 68:253-254.

• 25) Yin L, Sun M, Ilic Z. Leffert HL, Sell S:Derivation, characterization, and phenotypic variation of hepatic progenitor cell lines isolated from adult rats. Hepatology 2002, 35:315-324.
  pubmed

• 26) Hu Z, Evarts RP, Fujio K. Omori N, Omori M et al.:Expression of transforming growth factor α/epidermal growth factor receptor, hepatocyte growth factor/c-met and acidic fibroblast growth factor/fibroblast growth factor receptors during hepatocarcinogenesis. Carcinogenesis 1996, 17 (5):931-938.

• 27) Lee JM, Dedhar S, Kalluri R, Thompson EW:The epithelial-mesenchymal transition:new insights in signaling, developmcnt, and disease. J Cell Biol 2006, 172(7):973-981.

• 28) Giannelli G, Bergamini C, Fransvea E, Sgarra C, Antonaci S:Laminin-5 with transforming growth factor-β1 induces epithelial to mesenchymaltransition in hepatocellular carcinoma. Gastroenterology 2005, 129:1375-1383.

• 29) Suzuki A, Zhen YW, Kaneko S, Onodera M, Fukao K et al.:Clonal identification and characterization of self-renewing Pluripotent stem cells in the developing liver. The Journal of Cell Biology 2002, 156(1):173-184.

P.55 掲載の参考文献

• 1) Gronthos S, Mankani M, Brahim J, Robey PG, Shi S:Postnatal human dental pulp stem cells(DPSCs) in vitro and in vivo. Proc Natl Acad Sci 2000, 13625-13630.
  pubmed

• 2) Young CS, Terada S, Vacanti JP, Honda M, Bartlett JD, Yelick PC:Tissue engineering of complex tooth structures on biodegradable polymer scaffolds. J Dent Res 2002, 81:695-700.
  pubmed

• 3) Ohazama A, Modino SAC, Miletich I. Sharpe PT:Stem-cell-based tissue engineering of murine teeth. J Dent Res 2004, 83:518-522.
  pubmed

• 4) Duailibi MT, Duailibi SE, Young CS, Bartlell JD Vacanti JP, Yelick PC:Bioengineered teeth from cultured rat tooth bud cells. J Dent Res 2004, 83:523-528.

• 5) Ueda M, Tohnai I, Nakai H:Tissue engineering research in oral implant surgery. Artificial Organs 2001, 25:164-171.
  pubmed

• 6) Langer R, Vacanti Jp:Tissue engineereing. Science 1993, 260:920-926.
  pubmed

• 7) Mina M, Kollar EJ:The induction of odontogenesis in non-denal mesenchyme combined with early murine mandibular arch epithelium. Archs Oral Biol 1987, 32:123-127.

• 8) Honda MJ, Sumita Y, Kagami H, Ueda M:Histological and immunohistochemical studies of tissue engineered odontogenesis. Arch Histol Cytol 2005, 68:89-101.
  pubmed

• 9) Sumita Y, Honda MJ, Ohara T, Tsuchiya S, Sagara Het al.:Performance of collagen sponge as a 3-D scaffold for tooth-tissue engineering. Biomaterials 2006, 27:3238-3248.

• 10) Honda MJ, Ohara T, Sumita Y, Ogaeri T, Kagami H, Ueda M:Preliminary study of tissue-engineered odontogenesis in the canine jaw. J Oral Maxillofac Surg 2006, 64:283-289.

• 11) Honda MJ, Shinohara Y, Sumita Y, Tonomura A, Kagami H, Ueda M:Shear stress facilitates tissue-engineered odontogenesis. Bone 2006, 39:125-133.
  pubmed

• 12) Iwatsuki S, Honda MJ, Harada H, Ueda M:Cell proliferation in teeth reconstructed from dispersed cells of embryonic tooth germs in a three-dimensional scaffold. Eur J Oral Sci 2006, 114:310-317.

• 13) 賀来 亨:歯の再生医療. ティッシュエンジニアリング2005. 日本医学館, 東京, 2005, p156-164.

• 14) Thesleff L Sharpe P:Signaling networks regulating dental development. Mech Develop 1996, 67:111-123.

• 15) Jeranvall J, Thesleff I:Reiterative signaling and patterning during mammalian tooth morphogenesis. Mech Develop 2000, 92:19-29.

• 16) MacKenzie A, Ferguson MW, Sharpe PT:Expression patterns of the homeobox gene, Hox-8, in the mouse embryo suggest a role in specifying tooth initiation and shape. Development 1992, 115:403-420.
  pubmed

• 17) Vainio S, Karavnova I, Jowett A, Thesleff I:Identification of BMP-4 as a signal mediating secondary induction between epithelial and mesenchymal tissues during early tooth development. Cell 1993, 75:45-58.
  pubmed

• 18) Thelsleff I, Vaathtokari Al, Vainio S, Jowett A:Molecular mechanisms of cell and tissue interactions during early tooth development. Anatomical Records 1996, 245:151-161.

• 19) Chen YP, Bei M, Woo I, Satokata I, Maas R:Msx 1 controls inductive signaling in mammalian tooth morphogenesis. Development 1996, 122:3035-3044.

• 20) Neubuser A, Peters H, Balling R, Martin GR:Antagonistic interactions between FGF and BMP signaling pathways:amechanism for positioning the sites of tooth formation. Cell 1997, 90:247-255.

• 21) Thesleff I. Aberg T:Molecular regulation of tooth development. Bone 1999, 25:123-125.
  pubmed

• 22) Thesleff I:Epithelial-mesenchymal signaling regulating tooth morphogenesis. J Cell Sci 2003, 116:1647-1648.
  pubmed

• 23) Harada H, Kettunen K, Jung H-S, Mustonen T, Wang YA, Thesleff I:Localization of putative stem cells in dental epithelium and their association with Notch and FGF signaling. J Cell Biol 1999, 147:105-120.

• 24) Nadiri S, Kuchler-Bopp S, Haikel Y, Lesot H:Immunolocalization of BMP-2/-4, FGF-4, and Wnt10b in the developing mouse first lower molar. J Histochem Cytochem 2004, 52:103-112. tooth initiation and shape. Development 115:403-420, 1992.

• 25) Miura M, Gronthos S, Zhao M, Lu B, Fisher LW, Robey PG, Shi S:SHED:stem cells from human exfoliated deciduous teeth. Proc Natl Acad Sci 2003, 100:5807-5812.

• 26) Ten Cate AR, Sharpe PT, Roy S, Nancy A:Development of the tooth and its supporting tissues. Ten Cate's oral histology. development, structure, and function. (ed. Nancy A) , Mosby, St. Louis, 2003, p79-110.

• 27) ElNesr NM, Avery JK:Development of the teeth:root and supporting structures. Oral development and histology. 3rd ed. (eds. Avery JK, Steele PF) , Thieme, Stuttgart, 2001, p123-140.

• 28) Berkovitz BKB, Holland GR, Moxham BJ:Early tooth development Oral anatomy histology and embryology, third ed. (ed. Berkovitz BKB, Holland GR, Moxham BJ) , Mosby, Edinburgh, 2002, p290-303.

• 29) Piesco NP, Avery JK:Development of teeth:crown formation. Oral development and histology. 3rd ed. (ed. Avery J) , Thienle, Stuttgart, 2002, p72-107.

• 30) Luan X, Ito Y, Diekwisch TGH:Evolution and development of Hertwig's epithelial root sheath. Developmetal Dyanamics 2006, 235:1167-1180.

• 31) Abiko Y, Kanno H, Arai J, Nishimura M, Saitoh M, Kaku T:Apoptotic cell death at tooth eruption in rat molar observed by in situ labeling of nuclear DNA fragmentation. Jpn J Oral Biol 1995, 37:488-492.

• 32) Kaku T, Abiko Y:Cell death in oral tissues and disease. Oral Med Pathol 1997, 2:1-10.

• 33) Seo BM, Miura M, Gronthos S, Bartold PM, Batouli S et al.:Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet 2004, 364:149-155.
  pubmed

• 34) Nakao K, Morita R, Saji Y, Ishida K, Tomita Y et al.:The development of bioegineered organ germ method. Nat Methods 2007, 4:227-230.
  pubmed

P.64 掲載の参考文献

• 1) Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ et al.:Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
  pubmed

• 2) Ariizumi T, Asashima M:In vitro induction systems for analyses of amphibian organogenesis and body patterning. Int J Dev Biol 2001, 45:273-279.
  pubmed

• 3) Okabayashi K. Asashima M:Tissue generation from amphibian animal caps. Curr Opin Genet Dev 2003, 13:502-507.
  pubmed

• 4) Okabayashi K Asashima M:In vitro organogenesis using amphibian pluripotent cells. Proc Jpn Acad Ser B 2006, 82:197-207.
  pubmed

• 5) Asashima M, Nakano H. Shimada K, Kinoshita K, Ishii K et al.:Mesodermal induction in early amphibian embryos by Activin-A(Erythroid-Differentiation Factor) . Roux's Arch Dev Biol 1990, 198:330-335.

• 6) Ariizumi T, Moriya N, Uchiyama H, Asashima M:Concentration-dependent inducing activity of Activin A. Roux's Arch Dev Biol 1991, 200:230-233.

• 7) Ariizumi T, Sawamura K, Uchiyama H, Asashima M:Dose and time-dependent mesoderm induction and outgrowth formation by activin A in Xenopus laevis. Int J Dev Biol 1991, 35:407-414.
  pubmed

• 8) Moriya N Uchiyama H, Aasashima M:Induction of pronephric tubules by activin and retinoic acid in presumptive ectoderm of. Xenopus laevis. Dev Growth Differ 1993, 35:123-128.

• 9) Osafune K, Nishinakamura R, Komazaki S, Asashima M:In vitro induction of the pronephric duct in Xenopus explants. Dev Growth Differ 2002, 44:161-167.
  pubmed

• 10) Chan TC, Ariizumi T, Asashima M:Amodel system for organ engineering:Transplantation of in vitro induced embryonic kidney. Naturwissenschaften 1999, 86:224-227.

• 11) Moriya N, Komazaki S, Takahashi S, Yokota C, Asashima M:In vitro pancreas formation from Xenopus ectoderm treated with activin and retinoic acid. Dev Growth Differ 2000, 42:593-602.
  pubmed

• 12) Sogame A, Hayata T, Asashima M:Screening for novel pancreatic genes from in vitro-induced pancreas in Xenopus. Dev Growth Differ 2003, 45:143-152.
  pubmed

• 13) Kuroda H, Sakumoto H, Kinoshita K, Asashima M:Changes in the adhesive properties of dissociated and reaggregated Xenopus laevis embryo ceils. Dev Growth Differ 1999, 41:283-291.

• 14) Ariizumi T, Kinoshita M, Yokota C, Takano K, Fukuda K et al.:Amphibian in vitro heart induction:a simple and reliable model for the study of vertebrate cardiac development. Int J Dev Biol 2003, 47:405-410.

• 15) Nagamine K, Furue M, Fukui A, Asashima M:Induction of cells expressing vascular endothelium markers from undifferentiated Xenopus presumptive ectoderm by co-treatment with activin and angiopoietin-2. Zool Sci 2005, 22:755-761.

• 16) Ariizumi T, Asashima M:Head and trunk-tail organizing effects of the gastrula ectoderm of Cynops pyrrhogaster after treatment with activin A. Roux'sArch Dev Biol 1995, 204:427-435.

• 17) Yokota C, Ariizumi T, Asashima M:Patterns of gene expression in the core of Spemann's organizer and activin-treated ectoderm in Cynops pyrrhogaster. Dev Growth Differ 1998, 40:335-341.
  pubmed

• 18) Furue M, Myoishi Y, Fukui Y, Ariizumi T, Okamoto T, Asashima M:Activin A induces craniofacial cartilage from undifferentiated Xenopus ectoderm in vitro. Proc Natl Acad Sci USA 2002, 99(24):15474-15479.
  pubmed

• 19) Sedohara A, Komazaki S, Asashima M:In vitro induction and transplantation of eye during early Xenopus development. Dev Growth Differ 2003, 45:463-471.
  pubmed

• 20) Nakanishi M, Hamazaki TS, Komazaki S, Okochi H, Asashima M:Pancreatic tissue formation from murine embryonic stem cells in vitro. Differentiation 2006, 74:1-11.

• 21) Nishimura Y, Hamazaki TS, Komazaki S, Kamimura S, Okochi H, Asashima M:Ciliated cells differentiated from mouse embryonic Stem cells. Stem Cells 2006, 24:1381-1388.
  pubmed

• 22) Honda M, Hamazaki TS, Komazaki S, Kagechika H, Shudo K, Asashima M:RXR agonist enhances the differentiation of cardiomyocytes derived from embryonic stem cells in serum-free conditions. Biochem Biophys Res Commun 2005, 333:1334-1340.
  pubmed

• 23) Honda M, Kurisaki A, Ohnuma K, Okochi H, Hamazaki TS, Asashima M:N-cadherin is a useful marker for the progenitor of cardiomyocytes differentiated from mouse ES cells in serum-free condition. Biochem Biophys Res Commun 2006, 351:877-882.
  pubmed

• 24) Kurisaki A, Hamazaki TS, Okabayashi K, Iida T, Nishine T et al.:Chromatin-related proteins in pluripotent mouse embryonic stem cells are downregulated after removal of leukemia inhibitory factor. Biochem Biophys Res Commun 2005, 335:667-675.
  pubmed

• 25) Takahashi K, Yamanaka S:Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
  pubmed

P.73 掲載の参考文献

• 1) Fukuda K, Kikuchi Y:Endoderm development in vertebrates:fate mapping, induction and regional spcification. Dev Growth & Differ 2005, 47:343-355.
  pubmed

• 2) Hayashi K, Agata K, Mochii M, Yasugi S, Eguchi G et al.:Molecular cloning and the nucleotide sequence of cDNA for embryonic chicken pepsinogen:Phylogenetic relationship with prochymosin gene. J Biochem 1988, 103:290-296.

• 3) 八杉貞雄, 眞 昌寛, 福田公子:成長因子と消化器官の形態形成. ティッシュエンジニアリング 2005 (田畑泰彦, 岡野光夫・編), 日本医学館, 東京, 2005, p57-64.

• 4) Takiguchi K, Yasugi S, Mizuno T:Gizzard epithelium of chick embryos can express embryonic pepsinogen antigen, a marker protein of proventriculus. Roux's Arch Dev Biol 1986, 195:475-483.

• 5) Yasugi S:The role of mesenchymal tissue in the development of the gut. Connective Tissue 2000, 32:273-278.

• 6) 福田公子, 木村 航, 八杉貞雄:胃・腸形成における上皮間充織相互作用. 蛋白質 核酸 酵素 2006, 52:126-132.

• 7) Narita T, Saitoh K, Kameda T, Kuroiwa A, Mizutani M et al.:BMPs are necessary for stomach gland formation in the chicken embryo:A study using virally induced BMP-2 and Noggin expression. Development 2000, 127:981-988.
  pubmed

• 8) Shin M, Noji S, NeubUer A, Yasugi S:FGF10 is required for cell proliferation and gland formation in the stomach epithelium of the chicken embryo. Dev Biol 2006, 294:11-23.
  pubmed

• 9) Listyorini D, Yasugi S:Expression and function of Wnt5a in the development of the glandular stomach in chicken embryo. Dev Growth & Differ 2006, 48:243-252.
  pubmed

• 10) Koike T, Yasugi S:In vitro analysis of mesenchymal influences on the differentiation of stomach epithelial cells of the chicken embryo. Differentiation 1999, 65:13-25.
  pubmed

• 11) Tabata H, Yasugi S:Cultivation of chicken proventricular epithelial cells and their potential for differentiation. Dev Growth & Differ 1996, 38:499-507.

• 12) Matsuda Y, Wakamatsu Y, Kohyama J, Okano H, Fukuda K et al.:Notch signaling functions as a binary switch for the determination of glandular and luminal fates of endodermal epithelium during chicken stomach development. Development 2005, 132:2783-2793.
  pubmed

• 13) Narita T, Ishii Y, Nohno T, Noji S, Yasugi S:Sonic hedgehog expression in the developing chicken digestive organs is regulated by epithelial-mesenchymal interactions. Dev Growth & Differ 1998, 40:67-74.
  pubmed

• 14) Hojo M, Takada I, Kimura W, Fukuda K Yasugi S:Expression patterns of the chicken peroxisome proliferator-activated receptors(PPARs) during the development of the digestive organs. Mech Dev, Gene Expression Patterns 2006, 6:171-179.

• 15) Fukuda K, Kameda T, Saitoh K, Iba H, Yasugi S:Down-regulation of endodermal Shh is required for gland formation in chicken stomach. Mech Dev 2003, 120:801-809.
  pubmed

• 16) Sakamoto N, Fukuda K, Watanuki K, Sakai D, Komano T et al.:Role for cGATA-5 in transcriptional regulation of the embryonic chicken pepsinogen gene by epithelial-mesenchymal interactions in the developing chicken stomach. Dev Biol 2000, 223:103-113.
  pubmed

• 17) Watanuki K, Yasugi S:Analysis of transcription regulatory regions of embryonic chicken pepsinogen (ECPg) gene. Dev Dyn 2003, 228:51-58.
  pubmed

• 18) Tabata H, Yasugi S:Cultivation of chicken proventricular epithelial cells and their potential for differentiation. Dev Growth & Differ 1996, 38:499-507.

P.81 掲載の参考文献

• 1) 林 利彦:コラーゲン. ティッシュエンジニアリング 2005. (田畑泰彦・岡野光夫・編), 日本医学館, 東京, p31-36.

• 2) 林 利彦:コラーゲンスカフォールディング. バイオマテリアル-生体材料-2003, 21:210-211.

• 3) 大和雅之, 水野一乗, 今村保忠, 中里浩一, 安達栄治郎, 林 利彦:マトリックス. 細胞機能と代謝マップ II. 細胞の動的機能. (日本生化学会・編), 東京化学同人, 東京, 1998, p28-36.

• 4) 林 利彦:人の体は再生できるか-コラーゲンからさぐる細胞の設計・組立のメカニズム. マグロウヒル出版, 東京, 1991.

• 5) Myllyharju J, Kivirikko K:Collagens, modifying enzymes and their mutations in humans. flies and worms. TRENDS in Genetics 2004, 20:33-43.
  pubmed

P.86 掲載の参考文献

• 1) Matsumoto K, Shionyu M, Go M, Shimizu K, Shinomura T et al.:Distinct interaction of versican/PG-M with hyaluronan and link protein. J Biol Chem 2003, 278(42):41205-41212.

• 2) Plaas AH, Wong-Palms S, Roughley PJ, Midura RJ, Hascall VC:Chemical and immunological assay of the nonreducing terminal residues of chondroitin sulfate from human aggrecan. J Biol Chem 19. 97, 272(33):20603-20610.

• 3) Miyamoto T, Inoue H. Sakamoto Y, Kudo E, Naito T et al.:Identification of a novel splice site mutation of the CSPG2 gene in a Japanese family with Wagner syndrome. Invest Ophthalmol Vis Sci 2005, 46(8):2726-2735.

• 4) Li M, Shuman C, Fei YL Cutiongco E, Bender HA et al.:GPC3 mutation analysis in a spectrum of patients with overgrowth expands the phenotype of Simpson-Golabi-Behmel syndrome. Am J Med Genet 2001, 102(2):161-168.

• 5) Tsuchida K, Shioi J, Yamada S, Boghosian G, Wu A et al.:Appican, the proteoglycan form of the amyloid precursor protein, contains chondroitin suifate E in the repeating disaccharide region and 4-O-sulfated galactose in the linkage region. J Biol Chem 2001, 276(40):37155-37160.

• 6) Pellegrini L, Burke DF, von Delft F, Mulloy B, Blundell TL:Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin. Nature 2000, 407(6807):1029-1034.
  pubmed

• 7) Yannas IV, Burke JF, Gordon PL, Huang C. Rubenstein RH:Design of an artificial skin. H. Control of chemical composition. J Biomed Mater Res 1980, 14(2):107-132.

• 8) Yannas IV, Burke JF:Design of an artificial skin.I.Basic design principles. J Biomed Mater Res 1980, 14(1):65-81.
  pubmed

• 9) Kubo K, Kuroyanagi Y:Development of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and atelo-collagen combined with fibroblasts:fundamental evaluation. J Biomater Sci Polym Ed 2003, 14(7):625-641.
  pubmed

• 10) Honda MJ, Yada T, Ueda M, Kimata K:Cartilage formation by serial passaged cultured chondrocytes in a new scaffold:hybrid 75:25 poly(L-lactide-ε-caprolactone) sponge. J Oral Maxillofac Surg 2004, 62(12):1510-1516.

• 11) Sakai K, Kimata K, Sato T, Gotoh M, Narimatsu H et al.:Chondroitin sulfate N-acetylgalactosaminyltransferase-1 plays a critical role in chondroitin sulfate synthesis in cartilageJ Biol Chem 2007, 282 (6):4152-4161,

• 12) Sugiura N, Sakurai K, Hori Y, Karasawa K, Suzuki S et al.:Preparation of lipid-derivatized glycosarnino-glycalls to probe a regulatory function of the carbohydrate moieties of proteoglycans in cellmatrix interaction. J Biol Chem 1993, 268(21):15779-15787.
  pubmed

• 13) Kato S, Sugiura N, Kimata K, Kujiraoka T, Toyoda J et al.:Chondroitin sulfate immobilized onto culture substrates modulates DNA synthesis, tyrosine aminotransferase induction, and intercellular communication in primary rat hepatocytes. Cell Struct Funct 1995, 20(3):199-209.
  pubmed

• 14) Yoneda A, Asada M, Oda Y, Suzuki M, ImamuraT:Engineering of an FGF-proteoglycan fusion protein with heparin-independent, mitogenic activity. Nat Biotechnol 2000, 18(6):641-644.

• 15) Ashikari-Hada S, Habuchi H, Kariya Y, Kimata K:Heparin regulates vascular endothelial growth factor165-dependent mitogenic activity, tube formation, and its receptor phosphorylation of human endothelial cells. Comparison of the effects of heparin and modified heparins. J Biol Chem 2005, 280(36):31508-31515.
  pubmed

P.94 掲載の参考文献

• 1) Miner JH, Li C. Mudd JL, Go G, Sutherland AE:Compositional and structural requirements for laminin and basement membranes during mouse embryo implantation and gastrulation. Development 2004, 131:2247-2256.
  pubmed

• 2) Miyagoe Y, Hanaoka K, Nonaka I, Hayasaka M. Nabeshima Y et al.:Laminin α2 chain-null mutant mice by targeted disruption of the Lama2 gene:a new niodel of merosin(laminin 2)-deficient congenital muscular dystrophy. FEBS Lett 1997, 415:33-39.

• 3) Ryan MC, Lee K, Miyashita Y, Carter WG:Targeted disruption of the LAMA3 gene in mice reveals abnormalities in survival and late stage differentiation of epithelial cells. J Cell Biol 1999, 145:1309-1323.
  pubmed

• 4) Thyboll J, Kortesmaa J, Cao R, Soininen R, Wang L et al.:Deletion of the laminin α4 chain leads to impaired microvessel maturation. Mol Cell Biol 2002, 22:1194-1202.

• 5) Miner JH, Cunningham J, Sanes JR:Roles for laminin in embryogenesis:exencephaly, syndactyly, and placentopathy in mice lacking the laminin α5 chain. J Cell Biol 1998, 143:1713-1723.

• 6) Noakes PG, Gautam M, Mudd J, Sanes JR, Merlie Jp:Aberrant differentiation of neuromuscular junctions in mice lacking s-laminin/laminin β2. Nature 199. 5, 374:258-262.

• 7) Smyth N, Vatansever HS. Murray P, Meyer M, Frie Cet al.:Absence of basement membranes after targeting the LAMCI gene results in embryonic lethality due to failure of endoderm differentiation. J Cell Biol 1999, 144:151-160.

• 8) Meng X, Klement JF, Leperi DA, Birk DE, Sasaki T et al.:Targeted inactivation of murine laminin γ2-chain gene recapitulates human junctional epidermolysis bullosa. J Invest Dermatol 2003, 121:720-731.

• 9) Cosgrove D, Meehan DT, Grunkemeyer JA, Kornak JM, Sayers R et al.:Collagen COL4A3 knockout:a mouse model for autosomal Alport syndromc. Genes Dev 1996, 10:2981-2992.

• 10) Poschl E, Schlotzer-Schrehardt U, Brachvogel B, Saito K, Ninomiya Y et al.:Collagen IV is essential for basement membrane stability but dispensable for illitiation of its assembly during early development. Development 2004, 131:1619-1628.
  pubmed

• 11) Arikawa-Hirasawa E, Watanabe H, Takami H, Hassell JR, Yamada Y:Perlecan is essential for cartilage and cephalic development. Nat Genet 1999, 23:354-358.
  pubmed

• 12) Bader BL, Smyth N, Nedbal S, Miosge N, Baranowsky A et al.:Compound genetic ablation of nidogen l and 2 causes basement membrane defects and perinatal lethality in mice. Mol Cell Biol 2005, 25:6846-6856.

• 13) Nishiuchi R, Sanzen N, Nada S, Sumida Y, Wada Y et al.:Potentiation of the ligand-binding activity of integrin α3β1 via association with tetraspanin CD151. Proc Natl Acad Sci USA 2005, 102:1939-1944.

• 14) Ido H, Nakamura A, Kobayashi R, Ito S, Li S et al.:The requirement for glutamic acid residue at the third position from the carboxyl termini of the laminin γ chains in integrin binding by laminins. J Biol Chem 2007, (in press) .

• 15) Kreidberg JA, Donovan MJ, Goldstein SL, Rennke H, Shepherd K et al.:α3β1 integrin has a crucial role in kidney and lung organogenesis. Development 1996, 122:3537-3547.

• 16) Georges-Labouesse E, Messaddeq N, Yehia G, Cadalbert L, Dierich A et al.:Absence of integrin α6 leads to epidermolysis bullosa and neonatal death in mice. Nat Genet 1996, 13:370-373.

• 17) Mayer U, Saher G, Fassler R, Bornemann A, Echtermeyer F et al.:Absence of integrin α7 causes a novel form of muscular dystrophy. Nat Genet 1997, 17:318-323.

• 18) De Arcangelis A. Mark M, Kreidberg J, Sorokin L, Georges-Labouesse E:Synergistic activities of α3 and α6 integrins are required during apical ectodermal ridge formation and organogenesis in the mouse. Development 1999, 126:3957-3968.

• 19) Stephens LE, Sutherland AE, Klimanskaya IV, Andrieux A, Meneses J et al.:Deletion of β1 integrins in mice results in inner cell mass failure and peri-implantation lethality. Genes Dev 1995, 9:1883-1895.

• 20) Fassler R, Meyer M:Consequences of lack of β1 integrin gene expression in mice. Genes Dev 1995, 9:1896-1908.

• 21) Dowling J, Yu QC, Fuchs E:β4 integrin is required for hemidesmosome formation, cell adhesion and cell survival. J Cell Biol 1996, 134:559-572.

• 22) Brakebusch C, Grose R, Quondamatteo F, Ramirez A, Jorcano JL et al.:Skin and hair follicle integrity is crucially dependent on β1 integrin expression on keratinocytes. Embo J 2000, 19:3990-4003.

• 23) Graus-Porta D, Blaess S, Senften M, Littlewood-Evans A, Damsky C et al.:β1-class integrins regulate the development of laminae and folia in the cerebral and cerebellar cortex. Neuron 2001, 31:367-379.

• 24) Nishiuchi R, Takagi J, Hayashi M, Ido H, Yagi Y et al.:Ligand-binding specificities of laminin-binding integrins:a comprehensive survey of laminin-integrin interactions using recombinantα3β1,α6β1,α7β1 and α6β4 integrins. Matrix Biol 2006, 25:189-197.

• 25) Muller U, Wang D, Denda S, Meneses JJ, Pedersen RA et al.:Integrin α8β1 is critically important for epithelial-mesenchymal interactions during kidney morphogenesis. Cell 1997, 88:603-613.

• 26) Kiyozumi D, Sugimoto N, Sekiguchi K:Breakdown of the reciprocal stabilization of QBRICK/Frem1, Fras1, and Frem2 at the basement membrane provokes Fraser syndrome-like defects. Proc Natl Acad Sci USA 2006, 103:11981-11986.
  pubmed

P.99 掲載の参考文献

• 1) Langer R, Vacanti Jp:Tissue engineering. Science 1993, 260:920-926.
  pubmed

• 2) Bruder SP, Caplan AI:Bone regeneration through tissue engineering. Principles of tissue engineering. (eds. Lanza RP, Langer R, Vacanti Jp) , Academic Press, San Diego, 2002, p683-696.

• 3) Otto WR, Rao J:Tomorrow's skeleton staff:mesenchymal stem cells and the repair of bone and cartilage. Cell Prolif 2004, 37:97-110.
  pubmed

• 4) Balch OK, Collier MA, DeBault LE, Johnson LL:Bioabsorbable suture anchor(co-polymer 85/15 D, L lactide/glycolide) implanted in bone:correlation of physical/mechanical properties, magnetic resonance imaging, and histological response. Arthroscopy 1999, 15:691-708.

• 5) Kikuchi M, Matsumoto HN, Yamada T, Koyama Y, Takakuda K et al.:Glutaraldehyde cross-linked hydroxyapatite/collagen self-organized nanocom-posites. Biomaterials 2004, 25:63-69.

• 6) Komori T, Yagi H, Nomura S, Yamaguchi, A Sasaki Ket al.:Targeted disruption of Cbfal results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997, 89:755-764.

• 7) Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM et al.:The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002, 108:17-29.

• 8) St-Jacques B, Hammerschmidt M, McMahon AP:Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev 1999, 13:2072-2086.
  pubmed

• 9) Long F, Chung UI, Ohba S, McMahon J, Kronenberg HM et al.:Ihh signaling is directly required for the osteoblast lineage in the endochondral skeleton. Development 2004, 131:1309-1318.
  pubmed

• 10) Patel MS. Karsenty G:Regulation of bone formation and vision by LRP5. N Engl J Med 2002, 346:1572-1574.
  pubmed

• 11) Urist MR:Bone:formation by autoinduction. Science 1965, 150:893-899.
  pubmed

• 12) Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ et al.:Novel regulators of bone formation:molecular clones and activities. Science 1988, 242:1528-1534.
  pubmed

• 13) Chang H, Brown CW, Matzuk MM:Genetic analysis of the mammalian transforming growth factor-β superfamily. Endocr Rev 2002, 23:787-823.

• 14) Bell DM, Leung KK, Wheatley SC, Ng LJ, Zhou S et al.:SOX9 directly regulates the type-II collagen gene. Nat Genet 1997, 16:174-178.
  pubmed

• 15) Bi W, Deng JM, Zhang Z, Behringer RR, de Crombrugghe B:Soxg is required for cartilage formation. Nat Genet 1999, 22:85-89.

• 16) Bi W, Huang W, Whitworth DJ, Deng JM, Zhang Z et al.:Haploinsufficiency of Soxg results in defective cartilage primordia and premature skeletal mineralization. Proc Natl Acad Sci USA 2001, 98:6698-6703.

• 17) Akiyama H, Chaboissier MC, Martin JF, Schedl A, de Crombrugghe B:The transcription factor Soxg has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev 2002, 16:2813-2828.

• 18) Kalajzic I, Kalajzic Z, Kaliterna M, Gronowicz G, Clark SH et al.:Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage. J Bone Miner Res 2002, 17:15-25.
  pubmed

• 19) Ikeda T, Kamekura S, Mabuchi A, Kou I, Seki S et al.:The combination of SOX5, SOX6, and SOX9(the SOX trio) provides signals sufficient for induction of permanent cartilage. Arthritis Rheum 2004, 50:3561-3573.
  pubmed

• 20) Ohba S, Ikeda T, Kugimiya F, Yano F, Lichtler AC et al.:Identification of a potent combination of osteogenic genes for bone regeneration using embryonic stem(ES) cell-based sensor. FASEB J 2007, (in press) .

P.107 掲載の参考文献

• 1) 久保木芳徳, 滝田裕子, 吉本良太, 賀来 亨:人工細胞外マトリクスの幾何学. ティッシュエンジニアリング2006. (田畑泰彦, 岡野光夫・編), 日本医学館, 東京, 2006, p24-33.

• 2) 久保木芳徳, 郁 小兵, 滝田裕子, 吉本良太, 賀来 亨:人工細胞外マトリックスの幾何学の統一原理. 再生医療 2006, 3:20-30.

• 3) Westbroek P. Marin F:Amarriage of bone and nacre. Nature 1998, 392:861-862.
  pubmed

• 4) Seo SJ, Kim IY, Kim SH Choi YJ, Akaike T, Cho CS:Enhanced liver functions of hepatocytes cocultured with NIH3T3 in the alignate/garactosy-lated chitosan. Biomaterials 2006, 27:1487-1495.

• 5) Akiyama Y, Kikuchi A. Yamato M, Okano T:Ultrathin poly(N isopropylacrylamide) grafted layer on polystyrene surfaces for cell adhesion/ detachment control. Langmuir 2004, 20:5506-5511.
  pubmed

• 6) Yoshioka H, Mikami M, Mori Y et al.:Asynthetic hydrogel with thermoreversible gelation. Preparation and rheological properties. J Macromol Sci 1994, 31:113-120.

• 7) Zhang S, Holmes TC, DiPerasio CM, Hynes RO, Su X, Rich A:Self-complementary oligopeptide matriccs support mammalian cell attachment. Biomaterials 1995, 16:1385-1393.

• 8) Kuboki Y, Jin Q, Takita H:Geometry of carriers controlling phenotypic expression in BMP-induced osteogenesis and chondrogenesis. J Bone Joint Surg 2001, 83-A:S1-105-114.

• 9) Kuboki Y, Takita H, Mizuno M, Fujisawa R:Geometry of artificial extracellular matrices:a new paradigm from dental tissue engineering. Dentistry in Japan 2001, 37:42-50.

• 10) Jin Q-M, Takita H, Kohgo T, Atsumi K, Itoh H, Kuboki Y:Effects of geometry of hydroxyapatite as acell substratum in BMP-induced ectopic bone formation. J Biomed Mater Res 2000, 51:491-499.

• 11) Kuboki Y, Jin Q, Kikuchi M, Mamood J, Takita H:Geometry of artificial ECM:sizes of pores controlling phenotype expression in BMP-induced osteogenesis and chondrogenesis. Connect Tissue Res 2002;43(2-3):529-534.

• 12) Aoki N, Yokoyama A, Nodasaka Y, Akasaka T, Uo M et al.:Strikngly extended morphology of cell grown on carbon nanotube. Chem Lett 2006, 35:508-509.

• 13) Tsuruga E. Takita H, Itoh H, Wakisaka Y, Kuboki Y:Pore size of porous hydroxyapatite as the cell-substratum controls BMP-induced osteogenesis. J Biochem 1997, 121:317-324.
  pubmed

• 14) Kuboki Y, Takita H, Kobayashi D, Tsuruga E, Inoue M et al.:BMP-induced osteogenesis on the surface of hydroxyapatite with geometrically feasible and nonfeasible structures:Topology of osteogenesis. J Biomed Mater Res 1998, 39:190-199.
  pubmed

• 15) Kuboki Y, Kikuchi M, Takita H, Yoshimoto R, Nakayama Y et al.:Laser-perforated membranous biomaterials induced pore size-dependent bone induction when used as a new BMP carrier. Connect Tissue Res 2003, 44(Suppl 1):318-325.

• 16) Kuboki Y, Kaku T, Yoshimoto R, Kato T, Nemoto K et al.:Creation of haversian-type system by BMP-carriers with vasculature-inducing geometry, Presented at 5th International Confercnce of BMP at Nagoya. September 12-16, 2004.

• 17) 寺田典子, 高山満利子, 野村成規, 鈴木正彦, 河野牧子・他:人工ECMの幾何学:ハニカム長軸構造を持つβ-TCPにおける急速な血管・骨の新生誘導能について. 第19回代用臓器・再生医学研究会総会(札幌) 発表. 2007.

• 18) 福島和之, 富沢将司, 榎本光裕, 高橋誠他, 伊藤聡一郎・他:ハニカムコラーゲンを用いた損傷脊軸索の再生. 第6回日本再生医療学会総会発表. 再生医療2007, 6(増刊号):120.

• 19) Kuboki Y, Yoshimoto R, Kato H, Li D, Kaku T et al.:A New paradigm of titanium-bone bonding:creation of the collaboration zone between the both substances, by use of 3-D titanium web, which is attached to the titanium bulk by vacuum sintering. Archives of Bioceramics Research 2005, 5:146-149

• 20) Nakade T, Egashira N, Yoshimoto R, Kato H et al.:Dental implant system based on titanium webequipped titanium rod(TWT) induced collabo-ration zone between bone and rod of implant in beagle mandibles. Archives of Bioceramics Research 2005, 5:277-280.

• 21) Li D, Iku S, Nemoto K, Kokai Y, Odajima T et al.:Geometry of artificial ECM:three-dimensional structure of titanium-web(TW) promotes differentiation of human bone marrow mesenchymal cells into osteoblasts. J Hard Tissue Biol 2005, 14:333-334.

• 22) Bassett CAL, Herrmann I:Influence of oxygen concentration and mechanical factors on differentiation of connective tissue in vitro. Nature 1961, 190:460-461.

• 23) Banes AJ, Gilbert J, Taylor D, Monbureau O:A new vacuum-operated stress-providing instrument that applies static or variable duration cyclic tension or compression to cells in vitro J Cell Sci 1985, 75:35-42.

• 24) Orazizadeh M. Cartlidge C. Wright MO, Millward-Sadler SJ, Nieman J et al.:Mechanical responses and integrin associated protein expression by human ankle chondrocytes. Biorheology 2006, 43:249-258.
  pubmed

• 25) Burger EH, Klein-Nulend J:Responses of bone cells to biomechanical forces in vitro. Adv Dent Res 1999. 13:93-98.

• 26) Sikavitsas VI, Bancroft GN, Holtorf HL et al.:Mineralized matrix deposition by marrow stromal osteoblasts in 3D perfusion culture increases with increasing fluid shear forces. Proc Natl Acad Sci USA 2003, 100:14683-14688.
  pubmed

• 27) 前田雅彦, 広瀬志弘, 大串 始, 桐田忠昭:チタン製3次元培養担体を用いた間葉系細胞による骨再生. 再生医療 2007(6) (増刊号):291.

• 28) Ikegami M, Ishibashi O, Yoshikawa T, Shimomura J, Komori T et al.:Tensile stress induces bone morphogenetic protein 4 in preosteoblastic and fibroblastic cells, which later differentiate into osteoblasts leading to osteogenesis in the mouse calvariae in organ culture. J Bone Mineral Res 2001, 16:24-32.

• 29) Mizuno S, Watanabe S, Takagi T:Hydrostatic pressure promotes cellularity and proliferation on human fibroblasts in a three-dimensional collagengel/sponge. Biochem Eng J 2004. 20:203-208.

• 30) Muroi Y, Kakubo K, Nakata K:Effccts of compressive loading on human TMJ synoviumderived cells. J Dent Res 2007, (in press) .

• 31) Kanzaki M, Nagasawa M, Kojima I, Sato C, Naruse Ket al.:Molecular identification of a eukaryotic, stretch-activatcd nonselective cation channel. Science 1999, 285:882-886.

• 32) Ingber DE:Tensegrity I. Cell structure and hierachical systems biology. J Cell Science 2003, 116:1157-1173.

• 33) Ingber DE:Tensegrity II. How structural networks influence cellular information processing networks. J Cell Science 2003, 116:1397-1408.
  pubmed

• 34) Ingber DE, Heidemann SR, Lamoureux P, Buxbaum RE:Controversies in physiology, Opposing view on tensegrity as a structural framework for understanding cell mechanics. J Appl Physiol 2000, 9:1663-1678.

第2章 ティッシュエンジニアリング材料, 技術, 方法論の進歩

P.119 掲載の参考文献

• 1) 松田武久:バイオ人工血管のメカニクスとリモデリング. 血管医学 2004, 5:49-58.

• 2) 松田武久:生体力学場に感応する骨格基材の加工技術と再生医療. 日本再生医療学会雑誌 2005, 4:15-25.

• 3) Sonoda H, Takamizawa K, Nakayama Y, Yasui H, Matsuda T:Small-diameter compliant arterial graft prosthesis:Design concept of coaxial double tubular graft and its fabrication. J Biomed Mater Res 2001, 55:266-276.
  pubmed

• 4) Sonoda H, Takamizawa K, Nakayama Y, Yasui H, Matsuda T:Coaxial double-tubular compliant arterial graft prosthesis:time-dependent morphogenesis and compliance changes after implantation. J Biomed Mater Res 2003, 65A:170-181.

• 5) Kidoaki S, Kwon IK, Matsuda T:Mesoscopic spatiaI designs of nano-and micron-fiber meshes for tissue-engineering matrix and scaffold based on newly devised multilayering and mixing electrospinning techniques. Biomaterials 2005, 26:37-46.

• 6) Matsuda T, Ihara I, Kwon IK, Takamizawa K, Kidoaki S:Technical note mechano-active scaffold design of small-diameter artificial graft made of electrospun segmented polyurethane fabrics. J Biomater Res 2005, 73A:125-131.

• 7) Kwon IK, Kidoaki S, Matsuda T:Electrospun nanoto microfiber fabrics made of biodegradable copolyesters:structural characteristics, mechanical properties and cell adhesion potential. Biomaterials 2005, 26:3239-3939.

• 8) Ibusuki S, Fujii Y, Iwamoto Y, Matsuda T:Tissue-engineered cartilage using an injectable and in situ gelable thermoresponsive gelatin:fabrication and in vitro performances. Tissue Eng 2003, 9:371-384.
  pubmed

• 9) Ibusuki S, Iwamoto Y, Matsuda T:System engineered cartilage using Poly(N:isopropylacryl-amide-grafted gelatin as in situ formable scaffold:in vivo performances. Tissue Eng 2003, 9:1133-1142.

• 10) Xie J, Matsuda T:Mechanical loading-dependence of mRNA expressions of extracellular matrices of chondrocytes inoculated into elastomeric microporous poly(L-lactide-co-ε-caprolactone) scaffold. Tissue Engineering 2007, 13:29-40.

• 11) 安藤譲二, 山本希美子:日本生体医工学会誌 2007, 45:217.

• 12) 松本健郎:日本生体医工学会大会誌 2007, 45:109.

• 13) 鈴木 治:日本生体医工学会大会誌 2007, 45:168.

P.125 掲載の参考文献

• 1) Kobayashi A, Akaike T, Kobayashi K et al.:Enhanced adhesion and survival efficacy of liver cells in culture dishes coated with a lactose-carrying styrene homopolymer. Macromol Chem Rapid Commun 1986, 7:645-650.

• 2) Kobayashi K, Kobayashi A, Akaike T:Culturing hepatocytes on lactose-carrying Polystyrene layer via asialoglycoprotein receptor-mediated interactions. Methods Enzymol 1994, 247:409-418.
  pubmed

• 3) Kobayashi K, Goto M, Sekine T et al.:Regulation of differentiation and proliferation of rat hepatocytes by lactose-carrying polystyrene. Artif Organs 1992, 16:564-567.
  pubmed

• 4) Ise II, Sugihara N, Negishi N et al.:Low asialoglycoprotein receptor expression as markers for highly proliferative potential hepatocytes. Biochem Biophys Res Commun 2001, 285:172-182.

• 5) Hoshiba T, Cho CS, Murakawa A et al.:The effect of natural extracellular matrix deposited on synthetic polymers on cultured prirnary hepato-cytes. Biomaterials 2006, 27:4519-4528.

• 6) Hoshiba T, Nagahara H, Cho CS et al.:Primary hepatocyte survival on non-integrin-recognizable matrices without the activation of Akt signaling. Biomaterials 2007, 28:1093-1104.
  pubmed

• 7) Kim SH, Goto M, Akaike T:Specific binding of glucose-derivatized polymers to the asialogly-coprotein receptor of mouse primary hepatocytes. J Biol Chem 2001, 276:35312-35319.

• 8) Kim SH, Kim JH, Akaike T:Regulation of cell adhesion signaling by synthetic glycopolymer matrix in primary cultured hepatocyte. FEBS Lett 2003, 553:433-439.
  pubmed

• 9) Nagaoka M, Akaike T:Single amino acid sub-stitution in the mouse IgG-Fc region induces drastic enhancement of the affinity to protein A. Protein Eng 2003, 16:243-245.

• 10) Nagaoka M, Ise H, Akaike T:Immobilized E-cadherin model can enhance cell attachment and differentiation of primary hepatocytes but not proliferation. Biotecnol Lett 2002, 24:1857-1862.

• 11) Nagaoka M, Koshimizu U, Fukuda K et al.:E-cadherin-coated plates maintain pluripotent ES cells without colony formation. PLoS ONE 2006, 1:e15.
  pubmed

• 12) Ogiwara K, Nagaoka M, Cho CS et al.:Construction of a novel extracellular matrix using a new genetically engineered epidermal growth factor fused to IgG-Fc. Biotechnol Lett 2005, 20:1633-1637.
  pubmed

• 13) Ogiwara K, Nagaoka M, Cho CS et al.:Effect of photo-immobilization of epidermal growth factor on the cellular behaviors. Biochem Biophys Res Commun 2006, 345:255-259.
  pubmed

• 14) Engler AJ, Sen S, Sweeney HL et al.:Matrix elasticity directs stem cell lineage specification. Cell 2006, 126:677-689.
  pubmed

• 15) Lo CM, Wang HB, Dembo M et al.:Cell movement is guided by the rigidity of the substrate. Biophys J 2000, 79:144-152.
  pubmed

• 16) Harada I, Kim SG, Cho CS et al.:Asimple combined floating and anchored collagen gel for enhancing mechanical strength of culture system. J Biomed Mater Res A 2007, 80:123-130.

• 17) 岡野光夫:温度応答性高分子の動的特性とそのバイオメディカル応用. 高分子 2001, 50:438-441.

P.131 掲載の参考文献

• 1) Raghunath J, Rollo J, Sales KM, Butler PE, Seifalian AM:Biomaterials and scaffold design:key to tissue-engineering cartilage. Biotechnol Appl Biochem 2007, 46:73-84.
  pubmed

• 2) Moutos FT, Freed LE, Guilak F:Abiomimetic three-dimensional woven composite scaffold for functional tissue engineering of cartilage. Nat Mater 2007, 6:162-167.

• 3) Velema J, Kaplan D:Biopolymer-based biomaterials as scaffolds for tissue engineering. Adv Biochem Eng Biotechnol 2006, 102:187-238.
  pubmed

• 4) Teo WE, He W, Ramakrishna S:Electrospun scaffold tailored for tissue-specific extracellular matrix. Biotechnol J 2006, 1:918-929.
  pubmed

• 5) Dankers PY, Harmsen MC, Brouwer LA, van Luyn MJ, Meijer EW:Amodular and supramolecular approach to bioactive scaffolds for tissue engineering. Nat Mater 2005, 4:568-574.

• 6) Zhang H, Hussain I, Brust M, Butler MF, Rannard SP, Cooper AI:Aligned two-and three-dimensional structures by directional freezing of polymers and nanoparticles. Nat Mater 2005, 4:787-793.
  pubmed

• 7) Chen G, Ushida T, Tateishi T:Scaffold design for tisslle engineering. Macromole Biosci 2002, 2:67-77.

• 8) Li C, Vepari C, Jin HJ, Kim HJ, Kaplan DL:Electrospun silk-BMP-2 scaffolds for bone tissue engineering. Biomaterials 2006, 27:3115-3124.
  pubmed

• 9) Matthews JA, Wnek GE, Simpson DG, Bowlin GL:Electrospinning of collagen nanofibers. Biomacromolecules 2002, 3:232-238.
  pubmed

• 10) Chen G, Ushida T, Tateishi T:Preparation of poly(L-lactic acid) and poly (DL-lactic-co-glycolic acid) foams by use of ice microparticulates. Biomaterials 2001, 22:2563-2567.
  pubmed

• 11) Chen G, Ushida T, Tateishi T:Fabrication of PLGA-collagen hybrid sponge. Chem. Lett 1999, 561-562.

• 12) Chen G, Ushida T, Tateishi T:Hybrid biomaterials for tissue engineering:apreparative method of PLA or PLGA-collagen hybrid sponge. Adv Mater 2000, 12:455-457.

• 13) Chen G, Ushida T, Tateishi T:Abiodegradable hybrid sponge nested with collagen microsponges. J Biomed Mater Res 2000, 51:273-279.
  pubmed

• 14) Chen G, Ushida T, Tateishi T:Ahybrid network of synthetic polymer mesh and collagen sponge. J Chem Soc Chem Comm 2000, 16:1505-1506.

• 15) Chen G, Sato T, Ushida T, Ochiai N, Tetsuya T:Tissue engineering of cartilage using a hybrid scaffold of synthetic polymer and collagen. Tissue Engineering 2004, 10:323-330.

• 16) Chen G, Sato T, Ushida T, Hirochika R, Shirasaki R et al.:The use of a novel PLGA fiber/collagen composite web as a scaffold for engineering of articular cartilage tissue with adjustable thickness. J Biomed Mater Res 2003, 67A:1170-1180.

• 17) Chen G, Liu D, Tadokoro M, Hirochika R, Ohgushi H et al.:Chondrogenic differentiation of human mesenchymal stem cells cultured in a cobweb-like biodegradable scaffold. Biochem Biophys Res Commun 2004, 322:50-55.

• 18) Chen G, Tanaka T, Tateishi T:Osteochondral tissue engineering using a PLGA-Collagen hybrid mesh. Mater Sci Eng C 2006, 26:124-129.

• 19) Chen G, Akahane D, Kawazoe N, Yamamoto K, Tateishi T:Chondrogenic differentiation of mesenchymal stem cells in a leakproof collagen sponge. Mater Sci Eng C 2007, (in press) .

P.136 掲載の参考文献

• 1) Brown KL, Cruess RL:Bone and cartilage transplantation in orthopaedic surgery. A review. J Bone Joint Surg Am 1982, 64(2):270-279.
  pubmed

• 2) Enneking WF, Eady JL, Burchardt H:Autogenous cortical bone grafts in the reconstruction of segmental skeletal defects. J Bone Joint Surg Am 1980, 62(7):1039-1058.
  pubmed

• 3) Gitelis S, Saiz P:What'snew in orthopaedic surgery. J Am Coll Surg 2002, 194(6):788-791.

• 4) Younger EM, Chapman MW:Morbidity at bone graft donor sites. J Orthop Trauma 1989, 3(3):192-195.

• 5) Erbe EM, Marx JG, Clineff TD, Bellincampi LD:Potential of an ultraporous β-tricalcium phosphate synthetic cancellous bone void filler and bone marrow aspirate composite graft. Eur Spine J 2001, (Suppl2):S141-S146.

• 6) Langer R, Vacanti Jp:Tissue engineering. Science 1993, 260:920-926.
  pubmed

• 7) Holtorf HL, Sheffield TL, Ambrose CG, Jansen JA, Mikos AG:Flow perfusion culture of marrow stromal cells seeded on porous biphasic calcium phosphate ceramics. Ann Biomed Eng 2005. 33(9):1238-1248.
  pubmed

• 8) Goldstein AS, Juarez TM, Helmke CD, Gustin MC. Mikos AG:Effect of convection on osteoblastic cellgrowth and function in biodegradable polymer foam scaffolds. Biomaterials 2001, 22(11):1279-1288.

• 9) Sikavitsas VI, van den Dolder J, Bancroft GN, Jansen JA, Mikos AG:Influence of the in vitro culture period on the in vivo performance of cell/titanium bone tissue-engineered constructs using a rat cranial critical size defect model. J Biomed Mater Res A 2003, 67(3):944-951.

• 10) Sikavitsas VI, Bancroft GN, Mikos AG:ForInation of three-dimensional cell/polymer constructs for bone tissue engineering in a spinner flask and a rotating wall vessel bioreactor. J Biomed Mater Res 2002, 62(1):136-148.

• 11) Botchwey EA, Pollack SR, Levine EM, Laurencin CT:Bone tissue engineering in a rotating bioreactor using a microcarrier matrix system. J Biomed Mater Res 2001, 55(2):242-253.

• 12) Unsworth BR, Lelkes PI:Growing tissues in microgravity. Nat Med 1998, 4:901-907.
  pubmed

• 13) Sinha RK, Shah SA, Hume EL, Tuan RS:The effect of a 5-day space flight on the immature rat spine. Spine J 2002, 2(4):239-243.
  pubmed

• 14) Cartmell SH, Porter BD, Garcia AJ, Guldberg RE:Effects of medium perfusion rate on cell-seeded three-dimensional bone constructs in vitro. Tissue Eng 2003, 9:1197.
  pubmed

• 15) Wang Y, Uemura T, Dong J, Kojima H, Tanaka J, Tateishi T:Application of perfusion culture system improves in vitro and in vivo osteogenesis of bone marrow-derived osteoblastic cells in porous ceramic materials. Tissue Eng 2003, 9(6):1205-1214.
  pubmed

• 16) Meinel L, Karageorgiou V, Fajardo R, Snyder B, Shinde-Patil V et al.:Bone tissue engineering using human mesenchymal stem cells:effects of scaffold material and medium flow. Ann Biomed Eng 2004, 32(1):112-122.
  pubmed

• 17) van den Dolder J, Bancroft GN, Sikavitsas VI, Spauwen PH, Jansen JA, Mikos AG:Flow perfusion culture of marro stromal osteoblasts in titanium fiber mesh. J Biomed Mater Res A 2003, 64(2):235-241.

• 18) Bancroft GN, Sikavitsas VI, van den Dolder J, Sheffield TL, Ambrose CG et al.:Fluid flow increases mineralized matrix deposition in 3D perfusion culture of marrow stromal osteoblasts in a dose-dependent manner. Proc Natl Acad Sci USA 2002, 99(20):12600-12605.

• 19) Sikavitsas VI, Bancroft GN, Holtorf HL, Jansen JA, Mikos AG:Mineralized matrix deposition by marrow stromal osteoblasts in 3D perfusion culture increases with increasing fluid shear forces:Proc Natl Acad Sci USA 2003, 100(25):14683-14688.
  pubmed

• 20) Porter B, Zauel R, Stockman H, Guldberg R, Fyhrie D:3-Dcomputational modeling of media flow through scaffolds in a perfusion bioreactor. J Biomech 2005, 38(3):543-549.

• 21) Holtorf HL, Jansen JA, Mikos AG:Flow perfusion culture induces the osteoblastic differentiation of marrow stroma cell-scaffold constructs in the absence of dexamethasone. J Biomed Mater Res A 2005, 72(3):326-334.
  pubmed

• 22) Botchwey EA, Pollack SR, El-Amin S, Levine EM, Tuan RS, Laurencin CT:Human osteoblast-like cells in three-dimensional culture with fluid flow. Biorheology 2003, 40(1-3):299-306.
  pubmed

• 23) Pavalko FM, Chen NX, Turner CH, Burr DB, Atkinson S et al.:Fluid shear-induced mechanical signaling in MC3T3-E1 osteoblasts requires cytoskeleton-integrin interactions. Am J physiol 1998, 275:C1591-C1601.
  pubmed

• 24) Kapur S, Baylink DJ, Lau KH:Fluid flow shear stress stimulates human osteoblast proliferation and differentiation through multiple interacting and competing signal transduction pathways. Bone 2003, 32(3):241-251.
  pubmed

• 25) Jessop HL, Rawlinson SC, Pitsillides AA. Lanyon LE:Mechanical strain and fluid movement both activate extracellular regulated kinase(ERK) in osteoblast-like cells but via different signaling pathways. Bone 2002, 31(1):186-194.
  pubmed

• 26) McAllister TN, Frangos JA:Steady and transient fluid shear stress stimulate No release in osteoblasts through distinct biochemical pathways. J Bone Miner Res 1999, 14(6):930-936.
  pubmed

• 27) Lan CW, Wang FF, Wang YJ:Osteogenic enrichment of bone-marrow stromal cells with the use of flow chamber and type I collagen-coated surface. J Biomed Mater Res A 2003, 66(1):38-46.

• 28) Kreke MR, Goldstein AS:Hydrodynamic shear stimulates osteocalcin expression but not proliferation of bone marrow stromal cells. Tissue Eng 2004, 10(5-6):780-788.
  pubmed

• 29) Kreke MR, Huckle WR, Goldstein AS:Fluid flow stimulates expression of osteopontin and bone sialoprotein by bone marrow stromal cells in a temporally dependent manner. Bone 2005, 36(6):1047-1055.

• 30) Vunjak-Novakovic G et al.:Dynamic cell seeding of polymer scaffolds for cartilage tissue engineering. Biotechnol Prog 1998, 14:193-202.
  pubmed

• 31) Jadlowiec JA, Celii AB, Hollinger JO:Bone tissue engineering:recent advances and promising therapeutic agents. Expert Opin Biol Ther 2003, 3(3):409-423.

• 32) Lind M, Bunger C:Factors stimulating bone formation. Eur Spine J 2001:10(Suppl 2):S102-S109.

• 33) Yoon ST, Boden SD:Osteoinductive molecules in orthopaedics:basic science and preclinical studies. Clin Orthop Relat Res 2002, 395:33-43.
  pubmed

• 34) Du D, Furukawa K, Ushida T:Oscillatory perfusion seeding and culturing of osteoblast-like cells on porous beta-tricalcium phosphate scaffolds. J Biomed Mater Res(submitted) .

• 35) Vance J, Galley S, Liu DF, Donahue SW:Mechanical stimulation of MC3T30steoblastic cells in a bone tissue-engineering bioreactor enhances prostaglandin E, release. Tissue Eng 2005, 11(11-12):1832-1839.

• 36) Ponik SM, Triplett JW, Pavalko FM:Osteoblasts and osteocytes respond differently to oscillatory and unidirectional fluid flow profiles. J Cell Biochem 2006, 100(3):794-807.

• 37) Wu CC, Li YS, Haga JH, Wang N, Lian IY et al.:Roles of MAP kinases in the regulation of bone matrix gene expressions in human osteoblasts by oscillatory fluid flow. J Cell Biochem 2006, 98(3):632-641.

• 38) Li YJ, Batra NN, You L, Meier SC, Coe IA et al.:Oscillatory fluid flow affects human marrow stromal cell proliferation and differentiation. J Orthop Res 2004, 22(6):1283-1289.
  pubmed

• 39) You J, Yellowley CE, Donahue HJ, Zhang Y, Chen Q, Jacobs CR:Substrate deformation levels associated with routine physical activity are less stimulatory to bone cells relative to loading-induced oscillatory fluid flow. J Biomech Eng 2000, 122(4):387-393.

• 40) You J, Renly GC, Zhen X, Yellowley CE, Chen Q et al.:Osteopontin gene regulation by oscillatory fluid flow via intracellular calcium mobilization and activation of mitogen-activated protein kinase in MC3T3-EI osteoblasts. J Biol Chem 2001, 276(16):13365-13371.

• 41) Donahue TL, Haut TR, Yellowley CE, Donahue HJ, Jacobs CR:Mechanosensitivity of bone cells to oscillating fluid flow induced shear stress may be modulated by chemotransport. J Biomech 2003, 36(9):1363-1371.
  pubmed

• 42) Batra NN, Li YJ, Yellowley CE, You L, Malone AM et al.:Effects of short-term recovery periods on fluid-induced signaling in osteoblastic cells. Biomech 2005, 38(9):1909-1917.
  pubmed

• 43) Qin YX, Kaplan T, Saldanha A, Rubin C:Fluid pressure gradients, arising from oscillations in intramedullary pressure. is correlated with the formation of bone and inhibition of intracortical porosity. J Biomech 2003, 36(10):1427-1437.
  pubmed

P.146 掲載の参考文献

• 1) Kane BJ, Zinner MJ, Yarmush ML, Toner M:Liver-specific functional studies in a microfluidic array of primary Mammalian hepatocytes. Anal Chem 2006, 78:4291-4298.

• 2) 堀池靖浩, 宮原裕二:バイオチップとバイオセンサー. (高分子学会・編), 共立出版, 東京, 2006.

• 3) King KR, Wang S, Irimia D, Jayaraman A, Toner M et al.:Ahigh-throughput microfluidic real-time gene expression living cell array. Lab Chip 2007, 7:77-85.

• 4) Albrecht DR, Underhill GH, Wassermann TB, Sah RL, Bhatia SN:Probing the role of multicellular organization in three-dimensional microenvironments. Nat Methods 2006, 3:369-375.
  pubmed

• 5) Ziauddin J, Sabatini DM:Microarrays of cells expressing defined cDNAs. Nature 2001. 411:107-110.
  pubmed

• 6) Yamauchi F, Okada M, Kato K, Jakt ML, Iwata H:Array-based functional screening for genes that regulate vascular endothelial differentiation of Flk1-positive progenitors derived from embryonic. Biochim Biophys Acta, (accepted) .

• 7) Yamauchi F, Kato K, Iwata H:Spatially and temporally controlled gene transfer by electro-poration into adherent cells on plasmid DNA-loaded electrodes. Nucleic Acids Res 2004, 32:e187.

• 8) Silva JM, Mizuno H, Brady A, Lucito R, Hannon GJ:RNA interference microarrays:high-throughput loss-of-function genetics in mammalian cells. Proc Natl Acad Sci USA 2004, 101:6548-6552.
  pubmed

• 9) Fujimoto H, Yoshizako S, Kato K, Iwata H:Fabrication of cell-based arrays using micro-patterned alkanethiol monolayers for the parallel silencing of specific genes by small interfering RNA. Bioconjug Chem 2006, 17:1404-1410.

• 10) Otsuka H, Hirano A, Nagasaki Y, Okano T, Horiike Yet al.:Two-dimensional multiarray formation of hepatocyte spheroids on a microfabricated PEG-brush surface. Chembiochem 2004, 5:850-855.

• 11) Khademhosseini A Ferreira L, Blumling J 3rd, Yeh J, Karp JM et al.:Co-culture of human embryonic stem cells with murine embryonic fibroblasts on microwell-patterned substrates. Biomaterials 2006, 27:5968-5977.
  pubmed

• 12) Yamazoe H, Iwata H:Cell microarray for screening feeder cells for differentiation of embryonic stem cells. J Biosci Bioeng 2005, 100:292-296.
  pubmed

• 13) Kawasaki H, Mizuseki K, Nishikawa S, Kaneko S, Kuwana Y et al.:Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 2000, 28:31-40.
  pubmed

• 14) Revzin A, Sekine K, Sin A, Tompkins RG, Toner M:Development of a microfabricated cytometry platform for characterization and sorting of individual leukocytes. Lab Chip 2005, 5:30-37.
  pubmed

• 15) Di Carlo D, Wu LY, Lee LP:Dynamic single cell culture array. Lab Chip 2006, 6:1445-1449.
  pubmed

P.151 掲載の参考文献

• 1) Langer R, Vacanti Jp:Tissue engineering. Science 1993, 260:920-926.
  pubmed

• 2) Vacanti Jp, Vacanti CA:In principles of tissue engineering. (eds. Lanza RP, Langer R, Vacanti J) , Academic Press, San Diego, 2000, p3-7.

• 3) Kobayashi N, Fujiwara T, Westerman KA et al.:Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. Science 2000, 287:1258-1262.
  pubmed

• 4) Okitsu T, Kobayashi N Jun HS et al.:Transplantation of reversibly immortalized insulin-secreting human hepatocytes controls diabetes in pancreatectomized pigs. Diabetes 2004, 53:105-112.
  pubmed

• 5) Totsugawa T, Yong C, Soto-Gutierrez A et al.:Survival of liver failure pigs by transplantation of reversibly immortalized human hepatocytes with tamoxifen-mediated self-recombination. J Hepatol, (in press) .

• 6) 小林直哉:ヒト胚性幹細胞の肝細胞への分化誘導に関する基礎的研究-共同研究先のジェロン社を訪問して. Organ Biology 2005, 12(4):333-336.
  Medical*Online

• 7) Soto-Gutierrez A, Navarro-Alvarez N, Rivas-Carrillo JD, Chen Y, Yamatsuji T et al.:Differentiation of human embryonic stem cells to hepatocytes using deleted variant of HGF and poly-amino-urethane-oated nonwoven polytetrafluoroethylene fabric. Cell Transplant 2006, 15:335-341.

• 8) Chen Y, Soto-Gutierrez A, Navarro-Alvarez N, Rivas-Carrillo JD, Yamatsuji T et al.:Instant hepatic differentiation of human embryonic stem cells using activin A and a deleted variant of HGF Cell Transplant 2006, 15:865-871.

• 9) Soto-Gutierrez A, Kobayashi N, Rivas-Carrillo JD, Navarro-Alvarez N, Zhao D et al.:Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes. Nat Biotechnol 2006, 24(11):1412-1419.
  pubmed

• 10) Soto-Gutierrez A, Navarro-Alvarez N, Rivas-Carrillo JD, Fox IJ, Tanaka N, Kobayashi N:Stem cell-derived hepatocytes. Curr Opinion in Org Transpl 2006, 11:659-664.

• 11) Watanabe T, Shibata N, Westerman KA et al.:Establishment of immortalized human hepatic stellate scavenger cells to develop bioartificial livers. Transplantation 2003, 75:1873-1880.
  pubmed

• 12) Noguchi H, Kobayashi N, Westerman KA et al.:Controlled expansion of human endothelial cell populations by Cre/loxP-based reversible immortalization. Hum Gene Ther 2002, 13:321-
  pubmed

• 13) Maruyama M, Kobayashi N, Westerman KA et al.:Establishment of a highly differentiated immortalized human cholangiocyte cell line with SV40T and hTERT. Transplantation 2004, 77:446-451.
  pubmed

• 14) Matsumura T, Takesue M. Westerman KA et al.:Establishment of an immortalized human liver endothelial cell line with SV40T and hTERT. Transplantation 2004, 77:1357-1365.
  pubmed

• 15) Sternberg N, Hamilton D:Bacteriophage PI sitespecific recombination I. Recombination between loxP sites. J Mol Biol 1981. 150:467-486.

• 16) Narushima M, Kobayashi N, Okitsu T, Tanaka Y, Li SA et al.:A humanβ-cell line for transplantation therapy to control type 1 diabetes. Nat Biotechnol 2005, 23:1274-1282.

• 17) Tanaka K, Kobayashi N, Soto-Gutierrez A, Rivas-Carrillo JD, Navarro-Alvarez N et al.:Prolonged survival of mice with acute liver failure with transplantation of monkey hepatocytes cultured with an antiapoptotic pentapeptide V5. Transplantation 2006, 81:427-437.

• 18) Ikeda H, Kobayashi N, Tanaka Y, Nakaji S, Yong C et al.:Anewly developed bioartificial pancreas successfully controls blood glucose in totally pancreatectomized diabetic pigs. Tissue Eng 2006, 12:1799-1809.
  pubmed

• 19) Soto-Gutierrez A, Navarro-Alvarez N, Rivas-Carrillo JD, Tanaka K, Chen Y et al.:Construction and transplantation of an engineered hepatic tissue using a polyaminourethane-coatd nonwoven polytetrafluoroethylene fabric. Transplantation 2007, 83:129-137.

• 20) Kobayashi N, Okitsu T, Nakaji S, Tanaka N:Hybrid bioartificial liver:establishing a reversibly immortalized human hepatocyte line and developing abioartificial liver for practical use. J Artif Organs 2003, 6:236-244.
  pubmed

P.158 掲載の参考文献

• 1) 再生医療へのブレイクスルー. 遺伝子医学MOOK1. (田畑泰彦・編), メディカルドゥ, 大阪, 2004.

• 2) Leask A, Denton CP, Abraham DJ:Insights into the molecular mechanism of chronic fibrosis:the role of connective tissue growth factor in scleroderma. J Invest Dermatol 2004, 122:1-6.
  pubmed

• 3) Chatziantoniou C, Dussaule JC:Insights into the mechanisms of renal fibrosis:is it possible to achieve regression? Am J physiol Renal Physiol 2005, 289:F227-F234.
  pubmed

• 4) Liu Y:Renal fibrosis:New insights into the pathogenesis and therapeutics. Kidney Int 2006, 69:213-217.
  pubmed

• 5) Pinzani M, Rombouts K, Colagrande S:Fibrosis in chronic liver diseases:diagnosis and management. J Hepatol 2005, 42:S22-S36.
  pubmed

• 6) Rockey DC:Antifibrotic therapy in chronic liver disease. Clin Gastroenterol hepatol 2005, 3:95-107.
  pubmed

• 7) Bataller R, Brenner DA:Liver fibrosis. J Clin Invest 2005, 115:209-218.
  pubmed

• 8) Walter N, Collard HR, King Jr TE:Current perspectives on the treatment of idiopathic pulmonary fibrosis. Proc Am Thorac Soc 2006, 3:330-338.

• 9) Ask K, Martin EM, Kolb M, Gauldie J:Targeting genes for treatment in idopathic pulmonary fibrosis. Proc Am Thorac Soc 2006, 3:389-393.

• 10) Brinckerhoff CE, Rutter JL, Benbow U:Interstitial collagenases as markers of tumor progression. Clin Cancer Res 2000, 6:4823-4830.
  pubmed

• 11) Laviades C, Varo N, Diez J:Transforming growth factor β in hypertensives with cardiorenal damage. Hypertension 2000, 36:517-522.

• 12) Terui Y, Saito T, Watanabe H, Togashi H, Kawata S et al.:Effect of angiotensin receptor antagonist on liver fibrosis in early stages of chronic hepatitis C. Hepatology 2002, 36(4 Pt l):1022-1022.

• 13) Sharma K, Eltayeb BO, McGowan TA, Dunn SR, Alzahabi B et al.:Captopril-induced reduction of serum levels of transforming growth factor-β1 correlates with long-term renoprotection in insulin-dependent diabetic patients. Am J Kidney Dis 1999, 34:818-823.

• 14) Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E et al.:Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 1990, 346:371-374.

• 15) Jiang W, Yang CQ, Liu WB, Wang YQ, He BM et al.:Blockage of transforming growth factor β receptors prevents progression of pig serum-induced rat liver fibrosis. World J Gastroenterol 2004, 10:1634-1638.

• 16) Arias M, Sauer-Lehnen S, Treptau J, Janoschek N, Theuerkauf I et al.:Adenoviral expression of a transforming growth factor-β1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats. BMC Gastroenterol 2003, 3:29-29.

• 17) Iimuro Y, Nishio T, Morimoto T, Nitta T, Stefanovic Bet al.:Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat. Gastroenterology 2003, 124:445-458.

• 18) Matsuda Y, Matsumoto K, Yamada A, Ichida T, Asakura H et al.:Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis. Hepatology 1997, 26:81-89.
  pubmed

• 19) Yaekashiwa M, Nakayama S, Ohnuma K, Sakai T, Abe T et al.:Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. A morphologic study. Am J Respir Crit Care Med 1997, 156:1937-1944.
  pubmed

• 20) Mizuno S, Kurosawa T, Matsumoto K, Mizuno-Horikawa Y, Okamoto M et al.:Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease. J Clin Invest 1998, 101:1827-1834.

• 21) Taniyama Y, Morishita R, Aoki M, Hiraoka K, Yamasaki K et al.:Angiogenesis and antifibrotic action by hepatocyte growth factor in cardiomyopathy. Hypertension 2002, 40:47-53.
  pubmed

• 22) Tabata Y:Tissue regeneration based on growth factor release. Tissue Eng 2003, 9(Suppl 1):S5-S15.

• 23) Tabata Y:Significance of release technology in tissue engineering. Drug Discov Today 2005, 10(23-24):1639-1346.

• 24) Yamamoto M, Tabata Y:Tissue engineering by modulated gene delivery. Adv Drug Deliv Rev 2006. 58:535-554.
  pubmed

• 25) Oe S, Fukunaka Y, Hirose T, Yamaoka Y, Tabata Y:Atrial on regeneration therapy of rat liver cirrhosis by controlled release of hepatocyte growth factor. J Control Release 2003, 88:193-200.

• 26) Aoyama T, Yamamoto S, Kanematsu A, Ogawa O, Tabata Y:Local delivery of matrix metalloproteinase gene prevents the onset of renal sclerosis in streptozotocin-induced diabetic mice. Tissue Eng 2003, 9:1289-1299.
  pubmed

• 27) Kushibiki T, Nagata-Nakajima N, Sugai M, Shimizu A, Tabata Y:Delivery of plasmid DNA expressing small interference RNA for TGF-β type II receptor by cationized gelatin to prevent interstitial renal fibrosis. J Control Release 2005, 105:318-331.

第3章 臨床応用への道

P.168 掲載の参考文献

• 1) Spyrou Ge, Naylor IL:The effect of fibroblasts growth factor on scarring. British Journal of Plastic Surgery 2002, 55:275-282.
  pubmed

• 2) Sato H, Kishi K, Tanaka T, Kubota Y, Nakajima T et al.:Transplanted mesenchymal stem cells are effective for skin regeneration in acute cutaneous wounds(骨髄間葉系間細胞を利用したscarless wound healing). Cell Transplantation 2004, 13:405-412.

• 3) Singer AJ et al.:Adevelopment of a histomorphologic scale to quantify cutaneous scars after burns. Emerg Med 2000, 7:1083-1088.

• 4) Ono I, Yamashita T, Hida T, Jin HJ, Ito Y et al.:Combined administration of basic fibroblast growth factor protein and the hepatocyte growth factor gene enhances the regeneration of dermis in acute incisional wounds, Wound Repair Regeneration 2004, 12(1):67-79.

• 5) Akita S, Fukui M, Nakagawa H, Fujii T, Akino K:Cranial bone defect healing is accelerated by mesenchymal stem cells induced by coadministration of bone morphogenetic protein-2 and basic fibroblast growth factor. Wound Repair Regeneration 2004, 12(2):252-259.
  pubmed

• 6) Kishi K, Ohyama K, Satoh H, Kubota Y, Tanaka T et al.:Mutual dependence of murine fetal cutaneous regeneration and peripheral nerve regeneration. Wound Repair Regeneration 2006, 14(1):91-99.
  pubmed

• 7) Zuk PA, Zhu M, Misuno H et al.:Multi-lineage cells from human adipose tissue:implication for cell based therapics. Tissuc Eng 2001, 7:211-228.

• 8) Adam J, Katz, Ramon L, Hedrick MH et al.:Emerging approaches to the tissue engineering of fat. Clinics in Plastic Surgery 1999, 26(4):587-603.

• 9) 水野博司:脂肪由来幹細胞. 最新医学 2005. 60 (8):1755-1758.

• 10) 吉村浩太郎:脂肪由来幹細胞を利用した組織増大術. 小児外科 2004, 36:1444-1448.

• 11) Lendeckel S, Jodicke A, Christophis P et al.:Autologous stem cells(adipose) and fibrin glue used to treat widespread traumatic calvarial defects:case report. Journal of Cranio-Maxillofacial Surgery 2004, 32:370-373.
  pubmed

• 12) Garcia-Olmo D, Garcia-Arranz M. LG Garcia et al.:Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn's disease:a new cell-based therapy. Internationai Journal of Colorectal Disease 2003, 18:451-454.

• 13) Fraser JK, Schreiber R, Iledrick MH et al.:Plasticity of human adipose stem cells toward cndothelial cells and cardiomyocytes. Nature Clinical Practice Cardiovascular Medicine 2006, 3(suppl 1):S33-S37.

• 14) Asahara T, Murohara T, Sullivan A et al.:Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
  pubmed

• 15) Tateishi-Yuyama E, Matsubara H, Murohara T et al.:Therapeutic angiogenesis for patients with limb ischemia by autologous transplantation of bone marrow cells:apilot study and a randomized controlled triaL Lancet 2002, 360:427-435.

• 16) Miyamoto M, Yasutake M, Takano H et al.:Therapeutic angiogenesis by autologous bone marrow cell implantation in refractory chronic peripheral arterial disease using assessment of neovascularization by 99m Tc-tetrofosmin perfusioll scintigraphy. Cell Transplantation 2004, 13:429-437.
  pubmed

• 17) 水野博司, 赤石諭史:虚血性難治性皮膚潰瘍に対する骨髄単核球導入コラーゲンマトリックスの臨床応用. 日本形成外科学会会誌 2006, 26:726-732.

• 18) 西村 聡, 河合健一郎, 垣淵正男・他:放射線照射による創傷治癒障害に対する骨髄多血少板血漿(bm-PRP)を用いた治療. 第36回日本創傷治癒学会抄録集, 2006, p72.

• 19) Okamoto Y, Nakajima T et al.:Augumentation of skin flap survival by elective intra arterial infusion of prostagrandin E1:experimental and clinical studies. Annals of Plastic Surgery 1993, 30:154-158.

• 20) Kubota Y, Kishi K, Nakajima T et al.:Transposed endothelial progenitor cell augument the survival area of rat dorsal flaps. Cell Transplant 2003, 12:647-657.

• 21) 工藤 聡, 市岡 滋, 中塚貴志・他:虚血再灌流皮弁に対する骨髄細胞移植の有用性. 日本形成外科学会会誌 2004. 24:695-700.

P.176 掲載の参考文献

• 1) O'Connor NE, Mulliken J, Banks-Schlegel S et al.:Grafting of burns with cultured epithelium prepared from autologous epidermal cells. Lancet 1981, 1:75-78

• 2) Gobet R, Raghunath M, Altermatt S, Meuli-Simmen C, Benathan M et al.:Efficacy of cultured epithelial autografts in pediatric burns and reconstructive surgery. Surgery 1997, 121:654-661.
  pubmed

• 3) 熊谷憲夫:培養表皮による熱傷創の治療:TOPICS. 皮膚病診療 1988, 10:1088-1093.

• 4) Hickerson WL, Compton C, Fletchall S, Smith LR:Cultured epidermal autografts and allodermis combination for permanent burn coverage. Burns 1994, 20 (Suppl 1):S52-S55.

• 5) 熊谷憲夫, 仁科博道, 保坂登美子・他:ヒト培養表皮移植に関する研究-自家培養表皮移植による広範囲熱傷創の治療-. 日形会誌 1985, 5:463-474.

• 6) Kumagai, N, Nishina H, Tanabe H et al.:Clinical application of autologous cultured epithelia for the treatment of burn wounds and burn scars. Plast Reconstr Surg 1988, 82:99-108.
  pubmed

• 7) Rheinwald JG, Green H:Serial cultivation of human epidermal keratinocytes:the cell formation of keratinizing colonies from single cells. Cell 1975, 6:331-344.
  pubmed

• 8) Gallico GG, O'Connor NE, Compton GC et al.:Permanent coverage of large burn wounds with autologous cultured human epithelium. New Engl J Med 19. 84, 311:448-451.

• 9) Lavker RM, Sunn TT:Heterogeneity in epidermal basal keratinocytes:morphological and functional correlations. Science 1982, 215:1239-1241.

• 10) Rochat A, Kobayashi K, Barrandon Y:Location of stem cells of human hair follicles by clonal analysis. Cell 1994, 76:1063-1073.
  pubmed

• 11) Oshima H, Rochat A, Kedzia C et al.:Morphogenesis and renewal of hair follicles from adult multipotent cells. Cell 2002, 104:233-245.

• 12) Nishimura EK, Jordans SA, Oshima H et al.:Dominant role of the niche in melanocyte stem-cell fate determination. Nature 2002, 416:854-860.

• 13) 熊谷憲夫, 田辺博子:培養表皮移植による皮膚醜形の治療. 手術 1991, 45:692-698.

• 14) Kumagai N:Clinical application of autologous cultured epithelia for the treatment of burns and disfigurement of skin surfaces. Epithelial cell culture protocols. (ed. Wise C) , Human Press Inc, New Jersey, 2002, p185-196.

• 15) Kumagai N, Oshima H, Tanabe M et al.:Favorable donor site for epidermal cultivation for the treatment of burn scars with autologous cultured epithelium. Ann Plast Surg 1997, 38:506-513.
  pubmed

• 16) 大島秀男, 熊谷憲夫, 松崎恭一, 福士信哉, 田辺雅祥・他:培養表皮移植部位における皮表角層機能の検討. 形成外科 1996, 39:47-53.

• 17) Kumagai N, Uchikoshi T:Treatment of extensive hypomelanosis with autologous cultured epithelium. Ann Plast Surg 1997, 39:58-73.

• 18) Kumagai N:Grafting of autologous and allogeneic cultured epithelium after excision of tattoos. Eur J PIast Surg 1994, 17:312-315.

• 19) Cuono C, Langdon R, McGuire J:Use of cultured epidermal autografts as skin replacement after burn injury. Lancet 1986, 1:1123-1124.
  pubmed

• 20) Odessey R:Addendum:multicenter experience with cultured epidermal autograft for treatment of burns. J Burn Care 1992, 13:174-180.

• 21) Krupp S, Benathan M, Meuli M, Deglise B. Holzer E et al.:Current concepts in pediatric burn care:management of burn wounds with cultured autografts. Eur J Pediatr Surg 1992, 2:210-215.
  pubmed

• 22) 松崎恭一, 熊谷憲夫, 福士信哉, 大島秀男, 田辺雅祥・他:同種皮膚・白家培養表皮移植による広範囲熱傷患者の治療; 治療4年後の移植部の検討. 形成外科 1995, 38:193-200.

• 23) Braye F, Oddou L, Bertin-Maghit M, Belgacem S, Damour O et al.:Widely meshed autograft associated with cultured autologous epithelium for the treatment of major burns in children:report of 12 cases. Eur J Pediatr Surg 2000, 10:35-40.
  pubmed

• 24) Pellegrini G, Ranno R, Stracuzzi G, Bondanza S, Guerra L et al.:The control of epidermal stem cells (holoclones) in the treatment of massive full-thickness burns with autologous keratinocytes cultured on fibrin. Transplantation 1999, 68:868-879.
  pubmed

• 25) Ronfard V, Rives JM, Neveux Y et al.:Longterm regeneration of human epidermis on third degree burns transplanted with autologous cultured epithelium grown on a fibrin matrix. Transplantation 2000, 70:1588-1598.
  pubmed

• 26) Carsin H, Ainaud P, Le Bever H et al.:Cultured epithelial autografts in extensive burn coverage of severely traumatized patients:afive year single-center experience with 30 patients. Burn 2000, 26:379-387.

• 27) Ghalbzouri EI, Lamme E, Ponec M:Crucial role of fibroblasts in regulating epidermal morphogenesis. Cell Tissue Res 2002, 310:189-199.

• 28) 猪口貞樹:自家複合型培養皮膚移植. 医学のあゆみ 2002, 200:231-235.
  Medical*Online

• 29) Kumagai N Oshima H, Tanabe M et al.:Treatment of giant congenital nevi with cryopreserved allogeneic skin and fresh autologous cultured epithelium. Ann Plast Surg 1997, 39:483-488.
  pubmed

• 30) Boyce ST, Kagan RJ, Meyer NA, Yakuboff KP, Warden GD:The 1999 clinical research award. Cultured skin substitutes combined win Integra artificial skin to replace native skin autograft and allograft for the closure of excised full-thickness burns. J Burn Care Rehabil 1999, 20:453-461.

• 31) Boyce ST, Kagan RK, Yakuboff KP et al.:Cultured skin substitutes reduce donor skin harvesting for closure of excised, full-thickness burns. Ann Surg 2002, 235:269-279.

• 32) Maruguchi T, Maruguchi Y, Suzuki S et al.:Anew skin equivalent:keratinocytes proliferated and differentiated on collagen sponge containing fibroblasts. Plast Reconstr Surg 1994, 93:537-544.

• 33) 高見佳宏, 島崎修次, 山口 亮・他:無細胞真皮マトリックスを担体としたtissue engineered skin(複合型培養皮膚)の臨床応用. 形成外科 2004, 47:867-873.

• 34) Theopold C, Hoeller D, Velander P, Demling R, Eriksson E:Graft site malignancy following treatment of full-thickness burn with cultured epidermal autograft. Plast Reconstr Surg 2004, 114:1215-1219.
  pubmed

• 35) 熊谷憲夫, 田辺博子, 鈴木 出・他:創傷面への同種培養表皮移植-移植効果ならびに移植片の抗原性について. 日形会誌 1988, 8:574-585.

• 36) 熊谷憲夫, 田辺博子, 荻野洋一:熱傷創, 採皮創への自家および同種培養表皮移植. 熱傷 1990, 16:23-31.

• 37) Alvarez-Diaz C, Cuenca-Pardo J, Sosa-Serranao A, Jaurez-Aguilar E, Marsch-Moreno M et al.:Controlled clinical study of deep partial-thickness burn treated with frozen cultured human allogeneic epidermal sheets. J Burn Care Rehabil 2000, 21:291-299.

• 38) Arambula H, Sierra-Martinez E, Gonzalez-Aguirre NE, Rodriguez-Perez A, Juarez-Aguilar E et al.:Frozen human epidermal allogeneic cultures promote rapid healing of facial dermabrasion wounds. Dermatol Surg 1999, 25:708-712.
  pubmed

• 39) 黒柳能光:厚生科学再生医療プロジェクト-同種培養真皮の開発. 医学のあゆみ 2002, 200:247-251.

P.183 掲載の参考文献

• 1) Ohgushi H, Kitamura S, Kotobuki N, Hirose M, Machida H et al.:Clinical application of marrow mcsenchymal stem cells for hard tissue repair. Yonsei Med J 2004, 45(suppl):61-67.

• 2) Ohgushi H, Kotobuki N, Funaoka H, Machida H, Hirose M et al.:Tissue engineered ceramic artificial joint:ex vivo osteogenic differentiation of patient mesenchymal cells on total ankle joints for treatment of osteoarthritis. Biomaterials 2005, 26:4654-4661.
  pubmed

• 3) Pittenger MF, Mackay AM, Beck SC et al.:Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
  pubmed

• 4) Kotobuki N, Hirose M, Takakura Y et al.:Cultured autologous human cells for hard tissue regeneration:preparation and characterization of mesenchymal stem cells from bone marrow. Artif Organs 2004, 28:33-39.
  pubmed

• 5) Schwartz RE, Reyes M, Koodie L et al.:Multipotential adult progenitor cells from bone marrow differentiation into functional hepatocyte-like cells. J Clin Invest 2002, 109:1291-1302.

• 6) Deng W, Obrocka M, Fischer I et al.:In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP. Biochem Biophys Res Commun 2001, 282:148-152.
  pubmed

• 7) Makino S, Fukuda K, Miyoshi S et al.:Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 1999, 103:697-705.
  pubmed

• 8) Jiang Y, Jahagirdar BN, Reinhardt RL et al.:Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002, 418:41-49.
  pubmed

• 9) Jaiswal N, Haynesworth SE, Caplan AI et al.:Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 1997, 64:295-312.
  pubmed

• 10) 廣瀬志弘, 大串 始:臨床応用実用化に向けた細胞/再生組織のバリデーション. 医療機器と再生医療. (山根隆志・編), 情報機構, 東京, 2005,p129-134.

• 11) 大島 央, 大串 始:骨の再生医療. ティッシュエンジニアリング2005. (田畑泰彦, 岡野光夫・編), 日本医学館, 東京, 2005, p144-149.

• 12) Hirose M, Kotobuki N, Machida H et al.:Quantitative monitoring of in vitro mineralization process using fluorescent dyes. Key Eng Mater 2003, 240:715-718.

• 13) Uchimura E, Machida H, Kotobuki N et al.:In situ visualization and quantification of mineralization of culttlred osteogenetic cells. Calcif Tissue Int 2003, 73:575-583.
  pubmed

• 14) Kitamura S, Ohgushi H, Hirose M et al.:Osteogenic differentiation of human bone marrow-derived mesenchymal cells cultured on alumina ceramics. Artif Organs 2004, 28:72-82.
  pubmed

P.187 掲載の参考文献

• 1) Newman AP:Articular cartilage repair. Am J Sports Med 1998. 26:309-324.
  pubmed

• 2) Brittberg M, Lindahl A, Anders L et al.:Treatment of deep cartilage defects the knee with autologous chondrocyte transplantation. N Engl J Med 1994, 331:889-895.

• 3) Peterson L Minas T, Brittberg M et al.:Two-to 9-year outcome after autologous chondrocyte transplantation of the knee. Clin Orthop 2000, 374:212-234.
  pubmed

• 4) Ochi M, Uchio Y, Kawasaki K et al.:Transplantation of cartilage-like tissue made by tissue engineering in the treatment of cartilage defect of the knee. J Bone Joint Surg Br 2002, 84:571-578.
  pubmed

• 5) Ochi M, Uchio Y, Tobita M et al.:Current concepts in tissue engineering technique for repair of cartilage defect. Artif Organs 2001, 25:172-179.
  pubmed

• 6) Uchio Y, Ochi M, Adachi N et al.:Arthroscopic assessment of human cartilage stiffness of the femoral condyies and the pateila with a new tactile sensor. Med Eng Phys 2002, 24:431-435.
  pubmed

• 7) Ito Y, Ochi M, Adachi N, Sugawara K, Yanada S et al.:Repair of osteochondral defect with tissueengineered chondral plug in a rabbit model. Arthroscopy 2005, 21(10):1155-1163.

• 8) Yanada S, Ochi M, Adachi N, Nobuto H, Agung M et al.:Effects of CD44 antibody-or RGDS peptideimmobilized magnetic beads on cell proliferation and chondrogenesis of mesenchymal stem cells. J Biomed Mater Res A 2006, 77:773-784.
  pubmed

P.193 掲載の参考文献

• 1) Asahara T et al.:Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999, 85:221-228.
  pubmed

• 2) 藤井孝明, 米満吉和:FGF-2による血管新生因子群の階層的発現制御機構-機能をもつ血管の再生システム. 実験医学 2004, 22:1123-1129.
  Medical*Online

• 3) Losordo DW et al.:Gene therapy for myocardial angiogenesis:initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 1998, 98:2800-2804.
  pubmed

• 4) Hamano K et al.:Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease:clinical trial and preliminary results. Jpn Circ J 2001, 65:845-847.
  pubmed

• 5) Mangi AA et al.:Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003, 9:1195-1201.
  pubmed

• 6) Tabata Y et al.:Bone regeneration by basic fibroblast growth factor complexed with biodegradable hydrogels. Biomaterials 1998, 19:807-815.

• 7) Nakajima II et al.:Therapeutic angiogenesis by the controlled release of basic fibroblast growth factor for ischemic limb and heart injury:toward safety and minimal invasiveness. J Artif Organs 2004, 7:58-61.

• 8) Marui A et al.:Simultaneous application of basic fibroblast growth factor and hepatocyte growth factor to enhance the blood vessels formation. J Vasc Surg 2005, 41:82-90.
  pubmed

• 9) Iwakura A et al.:Intramyocardial sustained delivery of basic fibroblast growth factor improves angiogenesis and ventricular function in a rat infarct model. Heart Vessels 2003, 18:93-99.

• 10) Sakakibara Y et al.:Toward surgical angiogenesis using slow-released basic fibroblast growth factor. Eur J Cardiothorac Surg 2003, 24:105-111.
  pubmed

• 11) Ueyama K et al.:Development of biologic coronary artery bypass grafting in a rabbit model:revival of aclassic concept with modern biotechnology. J Thorac Cardiovasc Surg 2004, 127:1608-1615.

• 12) Takaba K et al.:Acombination of omental flap and growth factor therapy induces arteriogenesis and increases myocardial perfusion in chronic myocardial ischemia:Evolving concept of biologic coronary artery bypass grafting. J Thorac Cardiovasc Surg 2006, 132:891-899.

• 13) Iwakura A et al. Gelatin sheet incorporating basic fibroblast growth factor enhances healing of devascularized sternum in diabetic rats. Circulation 2001, 104 (suppl I):1325-1329.

• 14) Iwakura A et al.:Basic fibroblast growth factor may improve devascularized sternal healing. Ann Thorac Surg 2000, 70:824-828.
  pubmed

• 15) Sakaguchi G et al.:Control-released hepatocyte growth factor prevents the progression of heart failure in stroke-prone spontaneously hypertensive rats. Ann Thorac Surg 2005, 79:1627-1634.
  pubmed

P.200 掲載の参考文献

• 1) Soonpaa MH, Koh GY et al.:Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science 1994, 264:98-101.
  pubmed

• 2) Makino S, Fukuda K, Miyoshi S et al.:Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 1999, 103:697-705.
  pubmed

• 3) Terada N Hamazaki T et al.:Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2002, 416:542-545.
  pubmed

• 4) Alvarez-Dolado M, Pardal R et al.:Fusion of bone marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocyte. Nature 2003, 425:968-973.
  pubmed

• 5) Hakuno D et al.:Bone marrow-derived regenerated cardiomyocyte(CMG cells) express functional adrenergic and muscarinic receptors. Circulation 2002, 105:380-386.
  pubmed

• 6) Hattan N, Fukuda K et al.:Purified cardiomyocytes from bone marrow mesenchymal stem cells produce stable intracardiac grafts in mice. Cardiovasc Res 2005, 65:334-344.
  pubmed

• 7) Beltrami AP, Barlucchi L et al.:Adult cardiac stemcells are multipotent and support myocardial regeneration. Cell 2003, 114:763-776.

• 8) Oh H, Bradfute SB et al.:Cardiac progenitor cells from adult myocardium, homing, differentiation, and fusion after myocardial infarction. Proc Natl Acad Sci USA 2003, 100:12313-12318.
  pubmed

• 9) Hierlihy AM, Seale P, Lobe CG et al.:The post-natal heart contains a myocardial stem cell population. FEBS Lett 2002, 530:239-243.
  pubmed

• 10) Tomita Y, Matsumura K, Wakamatsu Y, Matsuzaki Y, Shibuya I, Kawaguchi H, Ieda M, Kanakubo S, Shimazaki T, Ogawa S, Osumi N, Okano H, Fukuda K:Cardiac neural crest cells contribute to the dormant multipotent stem cell in the mammalian heart. J Cell Biol 2005, 170:1135-1146.

• 11) Kehat L Kenyagin-karsenti D et al.:Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocyte. J Clin Invest 2001, 108:407-414.

• 12) Yuasa S, Itabashi Y et al.:Transient inhibition of BMP signaling by Noggin induces cardiomyocyte differentiationof mouse embryonic stem cells. Nat Biotechnol 2005, 23:607-611.

• 13) Okano T, Yamada N et al.:Anovel recovery system for cultured cells using plasma-treated polystyrene dishes grafted with poly(N-isopropy-lacrylamide) . J Biomed Mater Res 1993, 27:1243-1251.

• 14) Shimizu T, Yamamoto M et al.:Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res 2002, 90:40-48.

• 15) Itabashi Y, Miyoshi S, Fukuda K et al.:Anew method for manufacturing cardiac cell-sheets using fibrin-coated dishes and its application for electrophysiological studies by optical mapping. Artifi Org 2005, 29:95-103.

• 16) Ieda M, Fukuda K, Hisaka Y et al.:Endothelin-1 regulates cardiac sympathetic innervation in the rodent heart by controlling nerve growth factor expression. J Clin Invest 2004, 113:876-884.
  pubmed

P.206 掲載の参考文献

• 1) Miyagawa S, Sawa Y, Taketani S, Kawaguchi N, Nakamura T et al.:Myocardial regeneration therapy for heart failure:hepatocyte growth factor enhances the effect of cellular cardiomyoplasty. Circulation 2002, 105(21):2556-2561

• 2) Funatsu T, Sawa Y, Ohtake S, Takahashi T, Matsumiya G et al.:Therapeutic angiogenesis induced by myocardial injection of naked cDNA plasmid encoding hepatocyte growth factor in ischemic canine heart. J Thorac Cardiovasc Surg 2002, 124(6):1099-1105.

• 3) Kondo H, Sawa Y, Fukushima N. Matsumiya G, Miyagawa S et al.:Re-organization of cytoskeletal proteins and prolonged life expectancy caused by hapatocyte growth factor in a hamster model of latephase dilated cardiomyopathy. J Thorac Cardiovasc Surg, (in press) .

• 4) Memon IA, Sawa Y, Miyagawa S, Taketani S, Matsuda H:Acombined autologous cellular cardiomyoplasty with skeletal myoblasts and bone marrow cells in the canine hearts for ischemic cardiomyopathy. J Thorac Cardiovasc Surg 2005. 130:646-653.

P.211 掲載の参考文献

• 1) 江里健輔・他:人工血管の現状-臨床応用人工血管を中心に. 医学のあゆみ 1999, 188:671-675.

• 2) Deutsch M et al.:Clinical autologous in vitro endothelialization of infrainguinal ePTFE grafts in 100 patients:a 9-year experience. Surgery 1999, 126:847-855.
  pubmed

• 3) Noishiki Y et al.:Choice, isolation, and preparation of cells for bioartificial vascular grafts. Artif Org 1998, 22:50-62.

• 4) Matsuda T, Miwa H:Ahybrid vascular model biomimicking the hierarchic structure of arterial wall:neointimal stability and neoarterial regeneration process under arterial circulation. J Thorac Cardiovasc Surg 1995, 110:988-997.

• 5) Shin'oka T et al.:Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model. Circulation 1996, 94:II164-168.

• 6) Shin'oka T et al.:Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiovasc Surg 1998, 115:536-545; discussion 545-546.

• 7) Shin'oka T, Imai Y, Ikada Y:Transplantation of a tissue engineered pulmonary artery. New Eng J Med 2001, 344:532-533.
  pubmed

• 8) 日比野成俊, 今井康晴, 新岡俊治:ティッシュエンジニアリングによって作成されたグラフトを用いた肺動脈再建. 胸部外科 2002, 55(5):368-373.

• 9) Matsumura G, Narutoshi H. Yosihto I et al.:Successful application of tissue engineered vascular autografts:clinical experience. Biomateirals 2003, 24:2303-2308.

• 10) Isomatsu Y, Shin'oka T, Matsumura G et al.:Extracardiao total cavopulmonary connection using atissue-engineered graft. J Thorac Cardiovasc Sur 2003, 126(6):1958-1962.

• 11) Shin'oka T, Matsumura G, Hibino N, Naito Y, Watanabe M et al.:Midterm clinical results of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surgery 2005, 129:1330-1338.
  pubmed

P.219 掲載の参考文献

• 1) 吉江弘正:第1編, 歯周組織・再生歯周組織・再生のコンセプト. 再生歯科のテクニックとサイエンス-歯周・審美・インプラント-. (吉江弘正, 宮本泰和・ 編著), クインテッセンス出版, 東京, 2005, p 18-19.

• 2) 奥田一博:第1編, 歯周組織・再生 多血小板血漿 (PRP). 再生歯科のテクニックとサイエンス-歯周・審美・インプラント-(吉江弘正, 宮本泰和・編著), クインテッセンス出版, 東京, 2005, p56-66.

• 3) 奥田一博, 川瀬知之, 吉江弘正:多血小板血漿 (platelet rich plasma:PRP). 細胞増殖因子と再生医療. (松本邦夫, 田畑泰彦・編), メディカルレビュー社, 大阪, p386-392.

• 4) Kawase T, Okuda K, Saito Y, Amizuka N, Suzuki H, Yoshie H:Platelet-rich plasma(PRP) provides nucleus for mineralization in cultures of partially differentiated periodontal ligament cells. In Vitro Cell Dev Biol Animal 2005, 41:171-176.
  pubmed

• 5) Okuda K, Tai H, Tanabe K, Suzuki H, Sato T et al.:Platelet-rich plasma combined with a porous hydroxyapatite graft for the treatment of intrabony periodontal defects in humans:acomparative controlled clinical study. J Periodontol 2005, 76(6):890-898.

• 6) Kawase T, Okuda K, Saito Y, Yoshie H:In vitro evidence that the biological effects of platelet-rich plasma on periodontal ligament cells is not mediated solely by constituent transforming-growth factor-β or platelet-derived growth factor. J periodontol 2005, 76(5):760-767.

• 7) Okuda K, Kawase T, Momose M, Murata M, Saito Y et al.:Platelet-rich plasma contains high levels of platelet-derived growth factor and transforming growth factor-βand modulates the proliferation of periodontally related cells in vitro. J periodontol 2003, 74(6):849-857.

• 8) Kawase T, Okuda K, Wolff LF, Yoshie II:Platelet-rich plasma(PRP)-derived fibrin clot formation stimulates collagen synthesis in periodontal ligament and osteoblastic cells in vitro. J Periodontol 2003, 74(6):858-864.

• 9) Mizuno H, Hata K, Kojima K, Bonassar LJ, Vacanti CA, Ueda M:Anovel approach to regenerating periodontal tissue by grafting autologous cultured periosteum. Tissue Eng 2006, 12(5):1227-1235.

P.225 掲載の参考文献

• 1) 松野智宣:歯科における再生医学〜その現状〜. 日本歯科大学校友会・歯学会会報 2003, 29:15-19.

• 2) 春日井昇平:バイオマテリアルへの夢とその可能性. バイオマテリアル 2003, 21:355-356.

• 3) 越智光夫, 安達伸生:軟骨. 日本再生医療学会雑誌 2005, 4:26-32.

• 4) 矢永博子:培養軟骨移植法による新しい隆鼻術の開発. 形成外科 2005, 48:183-188.

• 5) Yanaga H, Koga M, Imai K Soejima C, Ohmori K:Clinical application of cultured autologous human auricular chondrocytes with autologous serum for craniofacial or nasal augmentation and repair. Plast Reconstr Surg 2006, 117:2019-2030.
  pubmed

• 6) Yamaoka H, Asato H, Ogasawara T, Nishizawa S, Takahashi T et al.:Cartilage tissue engineering using human auricular chondrocytes embedded in different hydrogel materials. J Biomed Mater Res 2006, 78:1-11.

• 7) 近津大地, 小笠原 徹, 星 和人, 高戸 毅:口腔外科領域の再生医療. ティッシュエンジニアリング 2006. 2006:144-145.

• 8) 石川 烈, 野口和行, 小牧基浩:歯周組織再生医療の最先端. 日本再生医療学会雑誌 2003, 2:41-49.

• 9) 高戸 毅, 宮本 学, 波利井清紀, 小室裕造, 米原啓之:片側下顎発育不全に対する下顎骨延長法. 日形会誌 1993, 13:187-197.

• 10) Takato T, Harii K, Komuro Y, Yonehara Y, Susami T:Mandibular lengthening by gradual distraction:Analysis using accurate skull replicas. Br J plast Surg 1993, 46:686-693.
  pubmed

• 11) 吉田雅司, 有村真一郎:自己血を応用した骨再生医療. 日本アフェレシス学会雑誌 2006, 25:204-209.

• 12) 上田 実:再生医療の現状と口腔外科領域への応用.日口外誌 2003, 49:491-500.

• 13) 木下靭彦, 天笠光雄:顎骨の再生医療. ティッシュエンジニアリング. 日本医学館, 東京, 2006, p137-143.

• 14) Kinoshita Y:Present and near-future of regenerative medicine in dentistry:regenerative treatment for the jawbone. The Bulletin of Kanagawa Dental College 2006, 34:89-91.

• 15) 田中純一, 加賀谷 保, 高橋雅幸, 高地義孝, 三尾和久・他:ハイドロキシアパタイトの下顎骨再建への使用経験. 基礎と臨床 1990, 24:7737-7740.
  Medical*Online

• 16) 樋口裕一, 中嶋英雄:失われた骨, 歯を取り戻す-人工骨・人工歯根の新材料-. Biophilia 2005:22-27.

• 17) 小林一夫, 緒方茂寛, 石原博史, 徳永和代, 中島光子・他:開頭術後変形に対するリン酸カルシウム骨ペーストの使用経験. 形成外科 2004, 47:631-635.

• 18) 上田 実:再生医療の現状と口腔外科領域への応用. 日口外誌 2003, 49:491-501.

• 19) 美島健二, 坪田一男, 斎藤一郎:涙腺・唾液腺の再生医療. 日本再生医療学会雑誌 2003, 2:53-58.

P.232 掲載の参考文献

• 1) Kenyon KR, Tseng SC:Limbal autograft transplantation for ocular surface disorders. Ophthalmology 1989, 96:709-722;discussion:722-723.

• 2) Tsubota K Toda I, Saito H, Shinozaki N, Shimazaki J:Recons truction of the corneal epitheliLim by limbal allograft transplantation for severe ocular surface disorders. Ophthalmology 1995, 102:1486-1496.

• 3) Tsubota K, Satake Y, Kaido M et al.:Treatnient of severe ocular-surface disorders with corneal epithelial stem-cell transplantation. N Engl J Med 1999, 340:1697-1703.
  pubmed

• 4) Shimazaki J, Kaido M. Shinozaki N et al.:Evidence of long-terIn survival of donor-derived cells after limbal allograft transplantation. Invest Ophthalmol Vis Sci 1999, 40:1664-1668.

• 5) Pellegrini G, Traverso CE, Franzi AT, Zingirian M, Cancedda R, De Luca M:Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium. Lancet 1997, 349:990-993.
  pubmed

• 6) Koizumi N, Inatomi T. Quantock AJ, Fullwood NJ, Dota A. Kinoshita S:Amniotic membrane as a substrate for cultivating limbal corneal epithelial cells for autologous transplantation in rabbits. Cornea 2000, 19:65-71.

• 7) Tsai RJ, Li LM, Chen JK:Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells. N Engl J Med 2000, 343:86-93.
  pubmed

• 8) Kim JC, Tseng SC:Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea 1995, 14:473-484.
  pubmed

• 9) Nishida K, Yamato M, Hayashida Y et al.:Functional bioengineered corneal epithelial sheet grafts from corneal stem cells expanded ex vivo on a temperature-responsive cell culture surface. Transplantation 2004, 77:379-385.
  pubmed

• 10) Nishida K, Yamato M, Hayashida Y et al.:Corneal reconstruction with tissue-engineered cell sheets composed of autologous oral mucosal epithelium. N Engl J Med 2004, 351:1187-1196.
  pubmed

• 11) Higa K, Shimmura S, Kato N et al.:Proliferation and differentiation of transplantable rabbit epithelial sheets engineered with or without an amniotic membrane carrier. Invest Ophthalmol Vis Sci 2007, 48:597-604.
  pubmed

• 12) Yoshida S, Shimmura S, Shimazaki J, Shinozaki N, Tsubota K:Serum-free spheroid culture of mouse corneal keratocytes. Invest Ophthalmol Vis Sci 2005, 46:1653-1658.
  pubmed

• 13) Yoshida S, Shimmura S, Nagoshi N et al.:Isolation of multipotent neural crest-derived stem cells from the adult mouse cornea. Stem cells(Dayton, Ohio) 2006, 24:2714-2722.

• 14) Uchino Y, Shimmura S, Miyashita H et al.:Amniotic membrane immobilized poly(vinyl alcohol) hybrid polymer as an artificial cornea scaffold that supports astratified and differentiated corneal epithelium. J Biomed Mater Res B Appl Biomater 2007, (inpress) .

• 15) Shimmura S, Miyashita H, Konomi K et al.:Transplantation of corneal endothelium with Descemet's membrane using a hyroxyethyl methacrylate polymer as a carrier. Br J Ophthalmol 2005, 89:134-137.
  pubmed

P.238 掲載の参考文献

• 1) Tropepe V. Coles BL. Chiasson BJ, Horsford DJ, Elia AJ et al.:Retinal stem cells in the adult mammalian eye. Science 2000, 287:2032-2036.
  pubmed

• 2) Fischer AJ, Reh TA:Muller glia are a potential source of neural regeneration in the postnatal chicken retina. Nat Neurosci 2001, 4:247-252.
  pubmed

• 3) Ooto S, Akagi T, Kageyama R, Akita J, Mandai M et al.:Potential for neural regeneration after neurotoxic injury in the adult mammalian retina. Proc Natl Acad Sci USA 2004, 101:13654-13659.
  pubmed

• 4) Lie DC, Colamarino SA. Song HJ, Desire L, Mira H et al.:Wnt signalling regulates adult hippocampal neurogenesis. Nature 2005, 437:1370-1375.
  pubmed

• 5) Kubo F, Takeichi M, Nakagawa S:Wnt2b inhibits differentiation of retinal progenitor cclls in the absence of Notch activity by downregulating the expression of proneural genes. Development 2005, 132:2759-2770.

• 6) Osakada F, Ooto S, Akagi T, Mandai M, Akaike A et al.:Wnt signaling Promotes regeneration in the retina of adult mammals. J Neurosci, (in press) .

• 7) Radtke ND, Aramant RB, Seiler MJ, Pctry HM, Pidwell D:Vision change aftcr sheet transplant of fetal retina with retinal pigment epithelium to a patient with retinitis pigmentosa. Arch Ophthalmol 2004, 122:1159-1165.

• 8) Ikeda H. Osakada F. Watanabe K, Mizuseki K. Ilaraguchi T et al.:Generation of Rx+/Pax6+ neural retinal precursors from embryonic stem cells. Proc Natl Acad Sci USA 2005, 102:11331-11336.

• 9) MacLaren RE, Pearson RA, MacNeil A, Douglas RH, Salt TE et al.:Retinal repair by transpiantation of photoreceptor precursors. Nature 2006, 444:203-207.

• 10) Nishida A, Takahashi M, Tanihara H, Nakano I, Takahashi JB et al.:Incorporation and differentia-tion of hippocampus-derived neural stem cells transplanted in injured adult rat retina. Invest Ophthalmol Vis Sci 2000, 41:4268-4274.

• 11) Suzuki T, Mandai M, Akimoto M, Yoshimura N, Takahashi M:The simultaneous treatment of MMP-2 stimulants in retinal transplantation eIlhances grafted cell migration into the host retina Stem cells 2006, 24:2406-2411.
  pubmed

• 12) Suzuki T, Akimoto M, Mandai M, Yoshimura N Swaroop A et al.:Chondroitinase ABC treatment enhances synaptogenesis between transplant and host neurons in model of retinal degeneration. Cell Transplantation, (in press) .

• 13) Yamagata M, Weiner JA, Sanes JR:Sidekicks:synaptic adhesion molecules that promote lamina-specific connectivity in the retina. Cell 2002, 110:649-660.
  pubmed

第4章 ティッシュエンジニアリングの周辺環境

P.248 掲載の参考文献

• 1) Miyata T, Taira T, Noisikin Y:Collagen engineering for biomaterial use. Clinical Materials 1992, 9:139-148.

• 2) Burke KE, Naughton G. Cassai N:Ahistological, immunological, and electron microscopic study of bovine collagen implants in the human. Ann Plast Surg 1985, 14:515-522.

• 3) Ochiya T, Takahama Y et al.:New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material-the Minipellet. Nature Medicine 1999, 5:707-710.
  pubmed

• 4) Takeshita F, Minakuchi Y et al.:Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo. PNAS 2005, 102:12177-1218.
  pubmed

• 5) Nokelainen M, Tu H et al.:High-level production of human type I collagen in the yeast Pichia pastoris. Yeast 2001, 18:797-806.
  pubmed

• 6) Tomita M, Munetsuna H et al.:Transgenic silkworms produce recombinant human type III procollagen in cocoons. Nat Biotechnol 2003, 21:52-56.
  pubmed

• 7) Merle C, Perret S et al.:Hydroxylated human homotrimeric collagen I in Agrobacterium tumefaciens-mediated transient expression and intransgenic tobacco plant. FEBS Lett 2002, 515:114-118.

• 8) Wada K, Tanaka Y et al.:In vitro reconstruction of athree-dimensional middle ear mucosal organ and its in vivo transplantation. Acta Otolaryngol 2006, 126:801-810.

• 9) 中田 研, 新城宏隆・他:コラーゲン担体を用いたヒト骨髄由来間葉系幹細胞三次元培養組織の力学的刺激に対する応答. 臨床リウマチ 2004, 16:380-382.

• 10) Okoshi T, Noishiki Y et al.:Long-term results of a new antithrombogenic cardiac wall substitute. ASAIO Trans 1989, 35:391-395.
  pubmed

• 11) Segura T, Anderson BC et al.:Crosslinked hyaluronic acid hydrogels:a strategy to functionalize and pattern. Biomaterials 1992, 26:359-371.

• 12) Camenisch TD, Spicer AP et al.:Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J Clin Invest 2000, 106:349-360.
  pubmed

• 13) Noble PW, McKee CM, Horton MR:Induction of inflammatory gene expression by low-molecularweight hyaluronan fragments in macrophages. The chemistry, biology and medical applications of hyaluronan and its derivatives. (ed. Laurent TC) , Portland Press. London, 1998, p219-225.

• 14) West DC, Kumar S:Hyaluronan and angiogenesis. Ciba Found Symp 1989, 143:187-201.
  pubmed

• 15) Laurent TC, Fraser JR:Hyaluronan. FASEB J 1992, 6:2397-2404.
  pubmed

• 16) Campoccia D, Doherty P et al.:Semisynthetic resorbable materials from hyaluronan esterification. Biomaterials 1998, 19:2101-2127.

• 17) Grigolo B, Roseti L et al.:Tissueengineering applications:cartilage lesions repair by the use of autologous chondrocytes. Reumatismo 2002, 54:364-371.

• 18) Mori M, Yamaguchi M et al.:Hyaluronan-based biomaterials in tissue engineering. Acta Histochem Cyrochem 2004, 37:1-5.

• 19) Fussenegger M, Meinhart J et al.:Stabilized autologous fibrin-chondrocyte constructs for cartilage repair in vivo. Ann Plast Surg 2003, 51:493-498.
  pubmed

• 20) Krishnan LK, Vijayan Lal A et al.:Fibrinolysisinhibitors adversely affect remodeling of tissues sealed with fibrin glue. Biomaterials 2003, 24:321-327.
  pubmed

• 21) Brown LF, Lanir N et al.:Fibroblast migration infibrin gel matrices. Am J Pathol 1993, 142:273-283.
  pubmed

• 22) Xu JW, Zaporojan V et al.:Injectable tissueengineered cartilage with different chondrocyte sources. Plast Reconstr Surg 2004, 113:1361-1371.
  pubmed

• 23) 特許出願公開公報 特開平 10-277143

• 24) Peretti GM, Xu JW et al.:Review of injectable cartilage engineering using fibrin gel in mice and swine models. Tissue Eng 2006, 12:1151-1168.
  pubmed

• 25) Hashizume H, Tamaki T et al.:Changes in the extracellular matrix on the surface of sintered bovine bone implanted in the femur of a rabbit:an-immunohistochemical study. J Orthop Sci 1998, 3:42-53.
  pubmed

• 26) Gilbert TW, Sellaro TL, Badylak SF:Decellularization of tissues and organs. Biomaterials 2006, 27:3675-3683.
  pubmed

• 27) Flanagan TC, Pandit A:Living artificial heart valve alternatives:a review. Eur Cell Mater 2003, 6:28-45.
  pubmed

• 28) Isenberg BC, Williams C, Tranquillo RT:Small diameter artificial arteries engineered in vitro. Circ Res 2006, 98:25-35.
  pubmed

• 29) 医薬発第1226号 (平成12年12月12日発)

P.269 掲載の参考文献

• 1) Bock AK, Ibarreta D, Rodriguez-Cerezo E:Human tissue-engineered products;Today'smarkets and future prospects. European Commission, Directorate-General Joint Research Center, October 2003.

• 2) Lysaght MJ, Hazlehurst A:Tissue Engineering 2004, 10:309-320.
  pubmed

• 3) Directive 2004/23/EC of the European Parliament and of the Council of 31 March 2004
  pubmed

• 4) Commission Directive 2006/86/EC of 24 October 2006

• 5) Bock AK, Rodriguez-Cerezo E, Husing B, Buhrlen B, Nusser M:Human tissue-engineered products; Potential socio-economic impacts of a new European regulatory framework for authorization, supervision and vigilance. European Commission. Directorate-General Joint Research Center, November 2005.

P.285 掲載の参考文献

• 1) Green WT Jr.:Articular cartilage repair. Behavior of rabbit chondrocytes during tissue culture and subsequent allografting. Clin Orthop Relat Res 1977:237-250.
  pubmed

• 2) Yannas IV, Burke JF et al.:Wound tissue can utilize a polymeric template to synthesize a functional extension of skin. Science 1982, 215:174-176.
  pubmed

• 3) Reinwald JG, Green H et al.:Serial cultivation of strains of human epidermal keratinocytes:the formation of keratinizing colonies from single cells. Cell 1975, 6:331-343.

• 4) Bell E et al.:Production of a tissue-like structure by contraction of collagen lattices by human fibriblasts of different proliferative potential in vitro. Proc Natl Acad Sci USA 1979, 76:1274-1278.

• 5) Langer R, Vacanti Jp:Tissue engineering. Science 1993, 260:920-926.
  pubmed

• 6) Nerem RM:Confronting the transplantation crisis:tissue engineering stem cells and gene therapies. Tissue Engineering. (ed. Elcin YM) , Kluwer Academic Plenum Publishers, New York, 2005, p1-9.

• 7) セル・フォースホームページ. http://cell-force.com/

• 8) Pei M, Solchaga LA, Seidel J, Zeng L, Vunjak-No-vakovic G, Caplan AI, Freed LE:Bioreactors mediate the effectiveness of tissue engineering scaffolds. FASEB J 2002, 16:1691-1694.

• 9) Naughton G:The advanced tissue science story. Sci Am 1999, 280:84-85.
  pubmed

• 10) Parenteau N:Skin:the first tissue-engineered products. Sci Am 1999, 280:83-84.
  pubmed

• 11) Keefe J, Wauk L, Chu S, DeLustro F:Clinical use of injectable bovine collagen:adecade of experience. Clin Mater 1992, 9:155-162.

• 12) Friedman PM, Mafong EA, Kauvar AN, Geronemus RG:Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg 2002, 28:491-494.
  pubmed

• 13) Watson D, Keller GS, Lacombe V, Fodor PB, Rawnsley J, Lask GP:Autologous fibroblasts for treatment of facial rhytids and dermal depressions. Apilot study. Arch Facial Plast Surg 1999, 1:165-170.

• 14) Boss WK Jr. , Usal H, Fodor PB, Chernoff G:Autologous cultured fibroblasts:aprotein repair system. Ann Plast Surg 2000, 44:536-542.

• 15) Boss WK, Usal H, Chernoff G, Keller GS, Lask GP, Fodor PB:Autologous cultures fibroblasts as cellular therapy in plastic surgery. Clinics in Plastic Surgery of North America 2000, 27:613-626.

• 16) Klein A:Tissue augmentation in clinical practice. Marcelle Dekker, New York, 1998, p335-347.

• 17) 蛯沢克己, 上田 実:皮膚陥凹変形に対する自家培養線維芽細胞治療. 医学のあゆみ 2006, 217:348-349.
  Medical*Online

• 18) Yoon ES, Han SK, Kim WK:Advantages of the presence of living dermal fibroblasts within restylane for soft tissue augmentation. Ann Plast Surg 2003, 51:587-592.
  pubmed

• 19) Han SK, Shin SH, Kang HJ, Kim WK:Augmentation rhinoplasty using injectable tissue-engineered soft tissue:a pilot study. Ann Plast Surg 2006, 56:251-255.

P.290 掲載の参考文献

• 1) 西田幸二:角膜の再生医療. 再生医療 2005. 4:494-501.
  Medical*Online

• 2) Shimazaki J, Konomi K, Shimmura S, Tsubota K:Ocular surface reconstruction for thermal burns caused by fireworks. Cornea 2006, 25, 139-145.
  pubmed

• 3) Hayashida Y, Nishida K, Yamamoto M et al.:Ocular surface reconstruction using autologous rabbit oral mucosal epithelial sheets fabricated ex vivo on a temperature-responsive culture surface.

• 4) 越智光夫, 安達伸生:軟骨. 再生医療 2005, 4:502-508.
  Medical*Online

• 5) Wakitani S, Imoto K, Yamamoto M et al.:Human autologous culture expanded marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage 2004, 10:199-206.

• 6) Valentin-Opran A, Wozney J, Csimma C et al.:clinical evaluation of recombinant human bone morphologic protein-2. Clin Orthop Relat Res 2002, 110-122.

• 7) 黒柳能光:培養表皮・培養真皮・培養皮膚の実用性. 再生医療 2005, 4:509-515.
  Medical*Online

• 8) Hansbrough JF, Boyve ST, Cooper ML et al.:Burn wound closure with cultured autologoous keratinocytes and fibroblasts attached to a collagen-glycosaminoglycan. JAMA 1989, 262:2125-2130.

• 9) Comerota AJ, Throm RC, Miller KA et al.:Naked plasmid DNA encoding fibroblast growth factor type lfor the treatment of end-stage unreconstructible lower extremity ischemia:preliminary results of a phase I trial. J Vasc Surg 2002, 35:930-936.

• 10) Seiler C, Pohl T, Wustmann K et al.:Promotion of collateral growth by granulocyte-macrophage colony stimulating factor in patients with coronary artery disease:arandomized, double-blind placebo-controlled study. Circulation 2001, 357:2012-2017.

• 11) 鈴木崇弘, 川本篤彦, 浅原孝之:血管再生医療. 再生医療 2005, 4:516-523.
  Medical*Online

• 12) Hamano K, Nishida M, Hirata K et al.:Local implantation of autologous bone marrow cells for therapeutic anfiofenesis in Patients with ischemic heart disease:clinical trial and preliminary results. Jpn Circ J 2001, 65:845-847.
  pubmed

• 13) Menasche P, Hagege AA, Scorsin M et al.:Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2002, 41:1078-1083.

• 14) 丹原圭一, 米田正始:難治性心不全に対する再生医療の現状と発展-徐放化細胞増殖因子と細胞移植療法を中心に. 再生医療 2005, 4:539-545.
  Medical*Online

• 15) 村上伸也, 島袋善夫, 北村正博, 山田 聡:歯周組織再生医療とDDS技術に期待するもの. 再生医療 2007,6:32-33.
  Medical*Online

• 16) 斉藤正寛:歯科再生医療の現状. 再生医療 2005, 4:55-62.

• 17) 河瀬 斌:「幹細胞の利用指針(厚生労働省案)」に対する日本再生医療学会の見解. 再生医療 2006, 5:430-431.

• 18) 佐藤洋一:細胞組織製品の前臨床安全性試験. 再生医療 2006, 5:189-192.
  Medical*Online

• 19) 再生医療臨床応用への道筋研究会:政策提言; 再生医療臨床応用への道筋 医療政策 4:日本医療政策機構, 東京, 2006.

P.298 掲載の参考文献

• 1) 文部科学省科学技術振興調整費 「先端医科学の認知に向けた社会的基盤調査:再生医療の認知に関する市民アンケート」 主任研究者 小林英司, 2006.

• 2) 牧野恒久:生殖医療と倫理問題. 再生医療 2005, 4 (3):94-99.

• 3) 牧野恒久:生殖医療と再生医療の不整合のもたらすもの. 再生医療 2006, 5(3):134-135.

• 4) 牧野恒久:再生医療の技術的現状と倫理・法律との整合性. 新医療 2006, 2:118-121.

自己細胞再生治療法法制化の考え方 より安全で効果的な先進医療の国家的普及に向けて

P.325 掲載の参考文献

• 1) 井上 肇:上皮幹細胞を用いた皮膚再生技術の実際. CMC出版, 2007, (印刷中).

• 2) Gallico et al.:Permanent coverage of large burn wounds with autologous cultured human epithelium. N Engl J Med 1984, 311:448-451.
  pubmed

• 3) Kumagai N et al.:Clinical application of autologous cultured epithelia for treatment of burn wounds and burn scars. Plast Reconstr Surg 1988, 82:99-108.
  pubmed

• 4) Oshima H, Inoue H:Permanent restoration of human skin treated with cultured epithelium. Iluman Cell 2002, 15:118-128.
  pubmed

• 5) Inoue H et al.:Application for regenerative medicine of epithelial cell culture-vistas of cultured epithelium. Congenit Anomal 2006, 46:129-134.

• 6) Peterson L, Brittberg M, Kiviranta I et al.:Autologous chondrocyte transplantation. Biomechanics and long-term durability. Am J Sports Med 2002, 30:2-12.
  pubmed

• 7) Ochi M, Uchio Y, Kawasaki K et al.:Transplantation of cartilage-like tissue made by tissue engineering in the treatment of cartilage defects of the knee. J Bone Joint Surg Br 2002, 84:571-578.
  pubmed

• 8) Wakitani S, Imoto K Yamamoto T et al.:Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage 2002, 10:199-206.
  pubmed

• 9) Ohgushi H, Caplan AI:Stem cell technology and bioceramics:From cell to gene engineering. J Biomed Mater Res 1999, 48:913-927.

• 10) Quarto R et al.:Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 2001, 344(5):385-386.
  pubmed

• 11) Ohgushi H, Kotobuki N, Funaoka H et al.:Tissue engineered ceramic artificial joint-ex vivo osteogenic differentiation of patient mesenchymal cells on total ankle joints for treatment of osteoarthritis. Biomaterials 2005, 26(22):4654-4656.
  pubmed

• 12) Kawaguchi H, Hayashi H, Mizuno N et al.:Cell transplantation for periodontal diseases:A novel periodontal tissue regenerative therapy using bone marrow derived stem cells. Clin Calcium 2005, 15:1197-1202.

• 13) 河口浩之:自家骨髄間葉系幹細胞移植法を用いた歯周組織再生療法. 日本歯周病学会誌 2006, 48(秋季特別号):69.

• 14) 村田雅史, 奥田一博, 百瀬 学・他:歯肉由来線維芽細胞とマトリックスから成る培養歯肉の根面被覆術への応用:症例報告. 日本歯周病学会誌 2004, 46(春季特別号):113.

• 15) Ueda M, Yamada Y, Ozawa R et al.:A Clinical report of injectable tissue-engineered bone applied for alveolar augmentation with simultaneous implant placement. Int J Periodontics Restorative Dent 2005, 25:129-137.

• 16) Yamada Y, Ueda M, Hibi H et al.:A novel approach to periodontal tissue regeneration with mesenchymal stem cells and platelet-rich plasma using tissue engineering technology:A clinical case report. Int J Periodontics Restorative Dent 2006. 26:363-369.
  pubmed

• 17) 日本移植学会:臓器移植ファクトブック2006.

• 18) Hagege AA, Marolleau Jp, Vilquin JT et al.:Skeletal myoblast transplantation in ischernic heart failure:long-term follow-up of the first phase I cohort of patients. Circulation 2006, 114(Suppl 1):1108-1113.

• 19) Hata H, Matsumiya G, Miyagawa S, Kondoh H et al.:Grafted skeletal myoblast sheets attenuate myocardial remodeling in pacing-induced canine heart failure model. J Thorac Cardiovasc Surg 2006, 132(4):918-924.

• 20) Tateishi-Yuyama E, Matsubara H, Murohara T et al.:Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bonemarrow cells:a pilot study and a randomised controlled trial. Lancet 2002, 360(9331):427-435.

• 21) Kawamoto A. Tkebuchava T, Yamaguchi J et al.:Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 2003, 107(3):461-468.
  pubmed

• 22) Mathur A, Martin JF:Stem cells and repair of the heart. Lancet 2004, 364(9429):183-192.
  pubmed

• 23) Dib N, Michler RE, Pagani FD et al.:Safety andfeasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy:four-year follow-up. Circulation 2005, 20:112(12):1748-1755.

• 24) Siminiak T, Kalawski R, Fiszer D et al.:Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury:phase I clinical study with 12 months of follow-up. Am Heart J 2004, 148(3):531-537.
  pubmed

• 25) http://www.mgbiotherapeutics.com/clinical/mgb_en_p_ct_clinicaltrials.asp